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1. INTRODUCTION 
The Siddha system dates back to 5000 B.C.The 18siddhars headed by Saint 
Agathiyar  had established the system.Lord siva, Lord Murugan, Saint Agasthiyar  hare 
symbalised the tamil literature which is  inseparable from siddha medicine and tamil 
tradition. 
            The current research was on Pattai Vallathagi to evaluate the safety and 
pharmacological activity in animal models. 
The drug Pattai vallathagi was indicated for Kuttam, Kiranthi,Kodiya Viranangal  
which was selected from the siddha literature“Siddha anuboga vaithiya navaneetha 
thirattu (part 10)” First edition-2010, pg.no:1581 authored by Hakkim P. Mohammed 
Abdulla sayub. 
The literary evidence of the drug  Pattai Vallathagi  strongly support that it 
possesses anti-inflammatory,analgesic and anti-histamine  activities  for that purpose. It 
has been selected for this study.   
All the ingredients  were identified and authenticated by the experts.The test drug 
was prepared by the given procedure. 
          The chemical analysis was done at Bio-chemistry lab, NIS. The Chemical analysis 
of the drug Pattai Vallathagi revealed the presence of Sulphate,Calcium, Iron, 
Potassium,Alkaloid, Tannin,  which provided the key ingredients present in the drug thus 
it accounts the efficacy of the drug. 
The ICP-OES  and HR SEM analysis was done at SAIF, IIT Madras. The ICP-
OES study revealed that the heavy metals like As, Pb, Cd were found below detection 
limit in the test drug. Calcium,Potassium,Phosphorus,Sodium,Sulphur were present 
In HR SEM analysis the particle size of  Pattai Vallathagi  was 1.2-2.4µ 
Preclinical evaluation of acute and sub-acute toxicity study was carried out in K.K 
College of Pharmacy, Gerugambakkam and sub-chronic toxicity study of the drug was 
carried out in  animal house, NIS, Chennai.  
Wistar  albino rats of  either sex of weight 150-200 gm were used for toxicity and 
pharmacological studies. The animals were kept under standard conditions 
12:12(day/night cycles) at room temperature in polypropylene cages. The animals were 
fed on standard pelleted diet and Potable water in polypropylene bottles ad libitum. The 
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animals were housed for one week prior to the experiments to acclimate to animal house 
conditions. 
In acute oral toxicity study, various dose level of Pattai Vallathagi   5, 50, 300 and 
2000 mg/kg b.w. was mixed with water  and was administered to female wistar albino rats 
which showed no abnormalities in external observation and necropsy examination and all 
the vital organs were normal. 
In Repeated  dose 28 days oral toxicity study and  Repeated dose 90 days  oral 
toxicity study , various doses level of Pattai Vallathagi  900 mg/kg and1800 mg/kg was 
mixed with water  and administered orally, did not show any  significant changes in 
hematological parameters and histopathological slides of various organs. 
The Pharmacological study  anti -inflammatory, analgesic and anti -histamine 
activity  of the drug was carried out in wistar albino rat, swiss albino mice and guinea pig  
as per OECD guideline in K.K College of Pharmacy, Gergambakkam revealed that the 
drug  Pattai Vallathagi exhibited significant   anti inflammatory, analgesic.and anti 
histamine activity  
 
       The above studies showed that the drug Pattai Vallathagi  was safe in animal models 
and may be tried for further studies to establish the clinical use. 
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2.  AIM AND OBJECTIVES 
 AIM 
 The aim of the study is to evaluate the Safety and Pharmacological profile of the 
test drug  “PATTAI VALLATHAGI’’ in animal models . 
 
OBJECTIVE 
         The following methodology was adopted to evaluate the safety and pharmacological 
activities of the test drug. 
 Review  of various information  (Siddha and modern)  relevant to the study. 
 Preparation of the drug as per  classical Siddha literature. 
 Analytical study of  the  prepared drug  
 Physico chemical and phytochemical analysis 
 Chemical analysis to evaluate acidic and basic radicals. 
 Heavy metal analysis 
 Elemental analysis 
 Analysis of Particle size 
 
 Screening the toxicity studys  in animal models 
 Acute oral toxicity study                       (OECD – 423 Guideline) 
  Repeated dose 28 days  oral toxicity  study   (OECD – 407 Guideline)  
  Repeated  dose 90 days oral  toxicity  study  (OECD – 408 Guideline) 
 
 Evaluation of pharmacological activities in Wister albino rat and mice and guinea 
pig 
 Anti- inflammatory (Cotton pellet induced granuloma method) 
 Analgesic   (Eddy‟s hot plate method) 
 Anti-histamine           (ileum cut terminal method) 
 
 
 
 
 
 
 
 
 
 
Materials and methods 
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3.  MATERIALS AND METHODS 
STANDARD OPERATIVE  PROCEDURE OF  PATTAI VALLATHAGI 
Drug selection : 
            To evaluate the efficacy of   Pattai Vallathagi  has been selected as per siddha 
literature   Siddha anuboga vaithiya navaneetha thirattu (part -10),pg.no: 1581 written 
by Hakkim P.Mohammed Abdulla sayub
 
Ingredients
(1)
  
 Purified cherangkottai (Semecarpus anacardium)    -     2 palam (70gms) 
 Purified Sesamum Seeds (Sesamum indicum )   -      8 palam (280gms) 
 Purified Nellikkai ganthagam (Purified Sulphur)    -     2palam (70gms) 
 Purified Turmeric (Curcuma longa)   -     2  palam (70gms) 
 Purified Parangi Pattai (Smilax chinensis )         -     4 palam (140gms) 
 Ellennai                                                          -     8 palam (280gms) 
  Purified Panai vellam                                      -      6 palam (210gms) 
Source of collection : 
        The druge were purchased from authorized country raw drug store in 
Chennai.Sulphur was purified and the medicine was prepared in the Gunapadam 
laboratory of National Institute of Siddha 
Identification and Authentication of the drug: 
       Mineral drug was authenticated by the chemist in Central Research Institute of 
Siddha, Arumbakkam,Chennai   All the plant meterials were identified and authenticated 
by the Botanist,    National Institute Of Siddha, Tambaram Sanatorium, Chennai 
Purification of the ingredients : 
Purification of Ganthagam
(5)
   
        Ganthagam  crushed into small pieces and it was put into an iron vessel and added  
butter into the vessels and  heated  until the sulphur was melted completely and it was 
transferred into other vessel which contains cow‟s milk.After cooling it was washed with 
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tap water.This process was repeated for 30 times.In every time the fresh butter and milk 
were used. 
Purification of  cherangkottai
(2)
  
       Take cherangkottai and tamarind leaf  in the ratio of 1:3and place it in a mud 
vessel,add water equivalent to eight times the amount of mixture and than boil it till it is 
reduced to 1/8 of the initial quantity. Then dry it in sunlight. The procedure is repeated  for 
seven times 
Purification of  parangichakkai 
(3)
 
       Dried tuber of Smilax china is steamed using milk, dried well and powdered. 
 Purification of Sesamum seeds 
(3) 
        Sesamum seeds are fried well. 
Purification of Turmeric
(3) 
        Outer peel is scrapped and dried in sunlight. 
Method  of drug preparation 
(1)
         
           Cherangkottai was placed in mortar and sesame seeds are added little by little and 
was crushed with pestle.  Then palm jaggery was added and crushed till content become 
electuary form. Then the power of remaining ingredients are added and crushed.The above 
contentswas mixed with gingelly oil and preserved in porcelain dish. 
Drug labelling : 
Name    :      Pattai Vallathagi 
Color                         :     Dark brown 
Therapeutic  Dose     :    1gm ,Twice  a day 
Adjuvent/vehicle       :    Water 
Date of preparation   :    20.7.2015 
Date of expiry            :    1 years from the date of manufacture 
Indications   :  Kuttam, Kiranthi,Kodiya viranangal. 
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INGREDIENTS OF PATTAI VALLATHAGI 
 
BEFORE  PURIFICATION                       AFTER  PURIFICATION 
Semecarpus anacardium         Cherangkottai 
                                                          
                                                 
 
   
     Smilax china              Parangi pattai 
                                                           
 
                                                     
 
 
Curcuma longa      Manjal                   
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   Sulphur          Ganthagam                                                                                    
                                                         
 
                     
 
 
Sesamum indicum  -Ell                          Palm jaggery-Panai vellam 
                                            
                                                       
 
 
 
Gingelly  - Oil 
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4.   REVIEW OF LITERATURE 
4.1 GUNAPADAM REVIEW 
gwq;fp;g; gl;il – Parangi pattai 
Botanical Name   :  Smilax  chinensis.Linn 
Family                  :  Liliaceae 
English Name      : China  root 
NtW ngah;fs;(4) 
        kJ];kpfk;> 
        kJ];kPfp> 
        gwq;fpr;rf;if> 
        rPdg;gl;il. 
gad;gLk; cWg;G: 
        fpoq;F. 
Organoleptic characters  
 Rit      :  ,dpg;G 
 jd;ik    :  jl;gk; 
 gphpT    :  ,dpg;G 
nra;if: 
       Nkfg;gpzptpyf;fp 
       clw;Nww;wp 
       J}a;ikahf;fp 
  
nghJFzk;: 
       jhfk; gythje; jhJel;lk; Gz;gpsit 
       Nkfq; fbfpue;jp  tPpo;%ye; -NjfKld; 
       Fl;l gfe;juNkw; nfhs;tkdk; Nghk;gwq;fpg; 
       gl;ilapid Ar;rhpj;Jg; ghh;. 
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 nghUs; : 
,jdhy;> ePh;Ntl;if> gw;gy tspNeha;> Gz;> gpsit> ePhpopT> fbtplk;> 
rpuq;F> %yKis> Klthjk;> FiwNeha;> Iak;> kfue;jg;Gz;> the;jp ,it ePq;Fk;. 
Mz;ik cz;lhk;. 
 
gwq;fpg;gl;il NrUk;  gpwkUe;Jfs; : 
   1.Nkf rpe;jhkzp nkOF  
   2.gwq;fpg;gl;il  gjq;fk;  
  3.rh;t Nkfj;njz;nza;  
    4.Nkfehj ijyk;   
    5;.gwq;fpg;gl;il ,urhadk; 
    6.,ur nkOF   
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Nruhq;nfhl;il  -Cherangkottai 
Botanical Name       :   Semecarpus anacardium.Linn 
Family                      :   Anacardiaceae 
English Name          :  Marking Nut Tree 
NtW ngah;fs;(4)  : 
            ty;yhjfp>  
            ty;yhjp> 
            gy;yhjfp> 
            vhpKfp> 
            ee;jptpj;J> 
            fpl;lhf;fdp nfhl;il. 
gad;gLk; cWg;G: 
           nfhl;il gUg;G. 
Organoleptic characters 
 Rit    :  ifg;G> tpWtpWg;G 
 jd;ik   :  ntg;gk; 
 gphpT    :  fhh;g;G  
nra;if : 
       clw;Nww;wp 
nghJFzk; : 
     Fl;lq; faNuhfq; nfhy;Yk; tplghfe; 
     Jl;le; jUfpUkp #iyAk; Nghk; - kl;lyUq; 
     $e;jd;kap Nyfpue;jpf; $l;lk; NghQ; nrq;ifapy; 
     Ve;J Nrq; nfhl;iljid Na. 
                              - 
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nghUs; : 
       ,J ngUNeha;> ,isg;G Neha;> eQ;Rfs;> #iy> jpkph;g;gil> fUg;Gg;gil> 
ntz;gil> jPuhf;fb> %yk;> tspNeha;fs;> Fd;kk; ,itfis Nghf;Fk;.  
       RUq;fr; nrhy;ypd; ahtUk; nkr;Rk; ,urj;jhy; jPUk; ngUNeha;fSk;> 
Nruhq;nfhl;ilahy; jPUk; 
 
  Nruhq;nfhl;il NrUk;  gpwkUe;Jfs; :; 
  1.,bty;yhjp ,sfk;  
  2. Mde;j tpNdhjr; #uzk;  
  3.ee;jp ik :  
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kQ;rs; - Manjal 
Botanical Name    :     Curcuma longa.Linn 
Family                    :   Zingiberaceae 
English Name       :   Turmeric 
 NtW ngaHfs;(4) 
             eprp> 
             gpjk;> 
            mhprdk;> 
            fhd;rhdp. 
 gad;gLk; cWg;G : 
           fpoq;F. 
Organoleptic  characters 
 Rit    :  fhh;g;G ifg;G  
 jd;ik   :  ntg;gk; 
 gpupT    :  fhh;g;G. 
nra;if: 
       kz%l;b 
       mfl;Ltha;tfw;wp    
       <uy;Njw;wp 
nghJf;Fzk;: 
      nghd;dpwkhk; Nkdp Gyhdhw;w Kk;NghFk; 
      kd;D GUl trpakhk; -gpd;dpnaOk; 
      thjgpj;j Njhlikak; thjk;Nghe; jPgdkhq; 
      $h;e;jkQ;r spd;fpoq;Ff;F. 
nghUs; : 
      ,jdhy;> the;jp> tsp> jP> Iaf;Fw;wk;> jiytyp> ePNuw;wk;> nts;is>  
%f;F ePh;gha;jy;> Itiftyp> tPf;fk;> tz;Lfb> ngUk;Gz; ,it Nghk;. 
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4. gid nty;yk; – Palm jaggary 
nghJFzk;;(4) 
     “--------------------------------------------jq;Fgid 
     nty;yj;jhy; thjgpj;jk;  tPWfgQ; rd;dpNeha; 
     ty;yUrp Fd;kkW khy;” 
                         -mfj;jpah; Fzthflk; 
gid nty;yj;jhy; Kf;Fw;wj;jhy; tUk; Neha;fSk;>Kg;gpzp>Ritapd;ik> Fd;kk; 
,itfSk; ePq;Fk;. 
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vs; - Ell 
Botanical Name     :  Sesamum  indicum,Linn 
Family                    :  Pedaliaceae 
English Name        :  Gingeli oil plant,Gingelly, sesame 
NtW ngah;fs;(4)  : 
               jpyk; 
gad;gLk; cWg;G: 
         ,iy> G+>fha;>tpij. 
Organoleptic Characters 
 Rit  :  ,dpg;G 
 jd;ik :  ntg;gk; 
 gphpT  :   ,dpg;G 
nra;if : 
         cukhf;fp 
         rpWePh;ngUf;fp 
         kykpsf;fp  
nghJFzk; : 
       “vs;SkUe; ijf;nfLf;Fk; vwdyhe; jpz;ikjUk; 
       cs;spiyiar; Nrh;f;Fk; cjpuj;ijj; - js;SkpU 
       fz;Zf; nfhspnfhLf;Fq; fhrKz;lhk; gpj;jKkhk; 
       gz;Zf; fplh;GupAk; ghh;” 
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vs; nea;  (ey;nyz;nza;)  - Sesamum oil 
  vs;is Ml;b vLf;Fk;  vz;nza;  ey;nyz;nza;.  
nra;if(4)  
       cs;soyhw;wp 
       kykpsf;fp 
       clYukhf;fp 
       twl;rpafw;wp. 
nghJFzk; : 
       Gj;jpeadf; Fsph;r;rp G+hpg;G nka;g;GsfQ; 
       rj;Jtq; fe;jp jdpapsik  -  nkj;jTz;lhq; 
       fz;Nzha; nrtpNeha; fghytoy; fhrNeha; 
       Gz;Nzha;Ngh nkz;nza;ahw; Nghw;W. 
                                    
nghUs; : 
       ey;nyz;nzapy; ,uz;L my;yJ ehY cr;rpf;fuz;basT xt;nthUehSk; 
nfhLj;Jf; nfhz;Ltu cly;G+hpf;Fk;.jpdT>gil>nrhwp rpuq;F ePq;fp Njhy; nkypAk;. 
 
                
 
 
                  
 
 
 
 
17 
 
fe;jfk; -Ganthagam 
NtW ngah;fs;(5)  
 gP[k; 
 rf;jp> 
 ehjk;> 
 ehw;wk;> 
 nghd;th;zp> 
 mjPjg;gpufhrk;> 
 nre;Jhuj;jhjp> 
 ,urRNuhzpjk;. 
        gjhu;j;j Fz rpe;jhkzpapy;  ney;ypf;fha; fe;jfk;>thz fe;jfk; vd;W 
2 tiffspd; Fzq;fs; $wg;gl;Ls;sJ.kUe;Jfspy; ifahsg;gLtJ ney;ypf;fha;    
fe;jfk;jhd;. 
fpilf;Fk; ,lq;fs; : 
 Neghsk;> fh\;kpuk;> Mg;fhdp];jhdk;> gu;kh Kjypa ,lq;fspy; fe;jfk;  
        fpilf;fpwJ. 
rpwg;G Fzq;fs; : 
 ,jDila ngaNu ,jw;F kzKz;nld;gij tpsf;fk;. 
 
 jhJ> jhtu nghUs;fspYk; fyg;Gw;W ,Uf;Fk;> 
 
Organoleptic characters 
 Rit        :   ifg;G> Jtu;g;G. 
 nra;iffs;   :  kykpsf;fp> 
                         cly; Njw;wp> 
                         tpah;it ngUf;fp> 
                         fpUkp ehrpdp. 
     fe;jfk; tpNufpapy; rpwg;ghf nray;gl;L Rug;ig mjpfg;gLj;Jk;. jtpu ,J 
Njhy;> mRfq;fspy; rspr;rt;tpDs;s Rug;igAk; mjpfhpf;Fk;. 
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ney;ypf;fha;f; fe;jpf;F ePs;gjpnzz; Fl;lke;jk; 
ty;iy ftpirFd;k thAfz;Nzha; - nghy;yh 
     tplf;fbtd; NkfNeha; tPWRuk; Ngjp 
     jplf;fpuf zPfgk;Nghe; Njh;. 
 
nghUs; : 
      ney;ypf;fha;f; fe;jpapdhy; gjpndz; Fl;lk;> ke;jk;> fy;yPuy; tPf;fk;> 
thjRuk;> ngUtapW> Fd;k thA Kjypait jPUk;.ngUtapWfspy; xd;whfpa 
ftpir> thj Ruk; NghFk;. 
       “khjh; kfit tsh;g;gJNgh NyAlk;ig 
        Ahjuth fj;Njw;wp ahf;ifapdhy; - kPjhf 
        Nktp alh;Nehapd; ntg;gj;ij khw;Wjyhw; 
        NwtpAu nkd;gJly; Njh;.” 
           fe;jfk;> jha; kfit tsh;g;gJ Nghy Neha;fspd; ntg;gj;ij khw;wp 
clk;igj; Njw;Wtpf;Fk;. 
fe;jfk; NrUk;  gpwkUe;Jks; : 
     1.fe;jf gw;gk;  
     2.gQ;rKf nre;Jhuk;  
     3.fe;jf Nyfpak;  
     4.fe;jf ijyk;  
     5.fe;jf urhazk; 
     6.MWKfr; nre;Jhuk;  
     7.,ur gw;gk;  
     8.kfh tre;j FRkhfhk;  
     9.Mde;j tpNdhj #uzk;  
                                                 
 
  
 
 
 
Botanical review 
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4.2.  BOTANICAL REVIEW 
Smilax china   _         Parangi pattai
 
Synonym - Smilax chinensis
(7) 
Family - Smilacaceae 
Common names: 
Catbriers, greenbriers, prickly- ivys and smilaxes 
 
Vernacular names 
Tamil  - Parangichekkai 
English - China root 
 
Parts used 
Tuber 
Organoleptic characters 
Taste  - Sweet 
Nature  - Coolant 
Division - Sweet 
 
Action 
  Depurative, Antisyphilitic 
 
Chemical components 
Tubers  - Tannin, Steroidal saponin Diosgenin, a steroidalsapogenin, is  
reported from S. menispermoidea. Other active compounds reported 
from various greenbrier species are Parillin (also sarsaparillin or 
smilacin), sarsapic acid, sarsapogenin, sarsaponin 
 
Pharmacological activity 
 Anti inflammatory, Antioxidant, Anticonvulsant. 
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Article related to the research : 
Acute toxicity study
(10)
  
         The methanolic extract and isolated flavonoid quercetin from the rhizome of S.china 
were found to be safe in the doses used.No abnormality in the gross behavioral studies and 
no mortality were noted in all the tested doses.  
Pharmocological Activity
(11) 
           The methanolic extract of Smilax chinensis in doses of 250mg/kg and 400mg/kg 
revealed significant anti inflammatory and analgesic activity.These results suggest that the 
ethyl acetate and methanolic extracts of Smilax chinensis Linn possesses analgesic and 
anti inflammatory activities  
Medicinal uses
(8) 
  Tubers are used to treat venereal diseases, rheumatic disorders and chronic 
skin affections. 
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Curcuma longa – Manjal 
 
Synonym  - Curcuma domestica Val.
(7) 
Family  -    Zingiberaceae 
 
Vernacular name 
Tamil   - Manjal, nisi, peetham 
Hindi   - Haldi 
English  - Turmeric 
 
Parts used 
  Rhizome 
 
Organoleptic characters 
Taste   - Acrid, Bitter 
Nature   - Hot 
Division  - Acrid 
 
Action 
Rhizome  - Antiseptic, anthelmintic, carminative, aromatic. 
 
Chemical constituents 
 Major 
 
Curcuminoids , the yellow colouring principles of which curcumin constitutes 50-60%. 
Curcumin , the major component is a well known anti- inflammatory agent. 
Minor 
      Desmethoxycurcumin, Bisdesmethoxycurcumin, dihydrocurcumin, Ukonan A, B, C, D 
     The best-studied compound is curcumin, which constitutes 3.14% (on average) of 
powdered turmeric. In addition, other important volatile oils include turmerone, atlantone, 
and zingiberene. 
  Some general constituents are sugars, proteins, and resins.
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Pharmacological activity 
            Anti – inflammatory. 
 
Article related the research : 
 Pharmocological activity
(12) 
         
     The related article revealed that the Curcuma longa aqueous drops definitely delayed 
healing of superficial corneal wounds (P less than 0.001),delayed healing of penetrating 
corneal wounds also and markedly reduced the tensile strength of corneal wounds. 
 
Medicinal uses
(8) 
 A fresh juice is commonly used in many skin conditions, including eczema, 
chicken pox, shingles, allergy, and scabies. 
 
 In India, turmeric has been used as a remedy for stomach and liver ailments, as 
well as topically to heal sores, basically for its supposed antimicrobial property. 
 
 The turmeric powder is applied over the cut with profuse bleeding in any part of 
the body. 
 
 It is mixed with gingelly oil and applied to the body to preent skin eruptions 
 The fumes of turmeric is used to relieve hysterical fits 
 In Catarrh and coryza the inhalation of the fumes of the burninf turmeric from the 
nostrils causes a copious mucous discharge and gives instant relief. 
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Semecarpous anacardium   -  cherangkottai 
Family  : Anacardiaceae
(7) 
Vernacular names 
Tamil   - Serangkottai 
English  - Marking nut 
Hindi   - Bhela 
Parts used: 
Fruit(seeds),  
 
Organoleptic characters 
Taste   - Bitter 
Nature   - Hot 
Division  - Acrid 
 
Action 
Kernal   - Carminative, cardiac tonic 
Oil   - Antiseptic, cholagogue 
 
Chemical Constituents: 
 Anacordic acid, Cardol, Riboflavin, Thiamine, Histidine, Isoleucine, leucine, 
Bhilawanol, Biflavanoids A, B, C, Oleic acid, Palmitic acid,  
Article related the research : 
 Pharmocological activity 
(13) 
              The related article revealed that the extract of Semicarpus anacardium indicated 
the potent anti inflammatory effect and therapeutic efficacy of Semecarpus anacardium 
LINN.nut extract against all phases of inflammation, is comparable to that of 
indomethacin. 
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Medicinal uses
(8) 
 The extract of the fruit is effective against human epidermoid carcinoma of the 
nasopharynx . 
 Ripe fruits are regarded as stimulant, digestive, nervine 
 It is a good cardiac tonic and a general respiratory stimulant 
 Oil  is used externally in gout, leprosy and leucoderma. 
 Exudate from the bark is useful in nervous debility and in leprous and venereal 
affections. 
 It is a powerful emmenagogue and producs good effect in dysmenorrhoea 
amenorrhoea, pelvic cellulitis and peritonitis. 
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Sesamum indicum - Ell 
Synonym  - Sesamum orientale L.
(7) 
Family  - Pedaliaceae 
 
Vernacular names 
Tamil   - Ell 
Hindi   - Thil 
English  - Sesame 
  
Parts used 
 Seeds 
 
Action 
Seeds  - diuretic,  laxative, demulcent. 
 
Variety 
        Three varieties of sesamum seeds are found; black,white, red or brown. The black 
variety is the most common and yields the best quality of oil and is best suited for 
medicinal purposes.  
 
Organoleptic character 
 
Taste   - Sweet 
Character  - Hot 
Division  - Sweet  
Chemical Constituents 
         Sesame seeds contain the lignans, sesamolin, sesamin, pinoresinol and lariciresinol, 
histidine, tryptophan, tyrosine, valine, ascorbic acid, biotin, folic acid, niacin, neutral 
lipids. 
Pharmacological activity: 
 Wound healing, Antitumour, Antibacterial, Antioxidant 
Medicinal uses
(8) 
 A plaster made from the seeds is applied to burns and scalds. 
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Borassus Flabellifer - Panai 
Family name  - Arecaceae
(7) 
English  - Palmyra 
Palm  Jaggery
(29) 
Color    :  Off white top pale yellowish white. 
Preparation   :  It is prepared by boiling the sap of palmyra palm. 
Physical  state  :  Amorphous Solid. 
 
            Palm jaggery is an extract derived from the palm trees.palm jaggery is an                   
excellent substitute for white sugar.It‟s an nutritious sweetenes.Palm jaggery is reported to 
have more nutritional and medicinal value than cane sugar.It‟s a good source of Vitamine 
B complex,and  it  also contain ascorbic acid.It is delicious and has mineral salts too. 
Palm jaggery benefit for health are : 
Rich source of minerals : 
           Palm jaggery is rich in essential  minerals.According to some studies it has 60 times 
more minerals than white sugar. 
 
Rich in nutrients : 
            Palm jaggery is rich in iron.It‟s regular  consumption increase hemoglobin level 
treats anemia. palm jaggery contain essential  nutrients like, Magnesium, 
Potassium.Megnesium is vital for the proper functioning of the nervas systems     and the 
Pattassium  regulates the blood pressure and the heart function. 
 
Active cleanse: 
           Palm jaggery also cleans up your system.It cleanses the respiratory tract,lung, 
stomach. 
 
Relieves constipation : 
            Palm jaggery is full of dietary fibers.These fibers help to treat constipation and 
indigestion.It also stimulates bowel movement. 
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Sesame oil (Gingelly oil ) 
               Sesame oil is an edible vegetable oil derived from sesame seeds.It‟s also known 
as til oil.Besides being used as a cooking oil in south India. 
 
Composition
(30) 
      Sesame oil is composed of the following fatty acids : 
                                                       Linoleic acid (41% of total), 
                                                       Oleic acid (39%), 
                                                       Palmitic acid (8%), 
                                                       Stearic acid (5%) and other in small amounts 
Nutritional value per 100 g 
 
Energy  3,699kJ (884 k cal) 
Carbohydrates 0.00g 
Fat 100.00g 
Saturated 14.200g 
Monounsaturted 39.700g 
Polyunsaturated 41.700g 
Vitamine E (9%)  1.40mg 
Vitamine K ( 13% )13.6µg 
 
Medicinal use        
The mixture of gingili oil and yellow of the egg is a good ointment for burns,    
itching etc. When there is burning sensation in the eyes, apply gingili oil over the thumbs 
of the foot. The oil is applied for cutaneous lesions of leprosy. The oil is given internally 
for gonorrhea 
  
 
 
 
Mineralogical review 
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4.3 MINERALOGICAL REVIEW 
Sulphur
(9) 
 
 It is a non metallic element found free in beds of gypsum and in a state of 
sublimation in regions of extinct volcanoes and in combination with several ores called 
pyrites as sulphates and sulphides of iron, copper, lead, zinc, mercury. 
 
 Sulphur is a chemical element with symbol S and atomic number 16. It is an 
abundant, multivalentnon-metal. Elemental sulfur is a bright yellow crystalline solid when 
at room temperature.  
Synonyms 
 Sulphur, Brime stone, Colloidal sulphur, floor of sulphur 
Distribution 
 It occurs in Nepal, Kashmir, Afghanistan and Burma. 
Physical characters 
 Colour is a strong yellow colour in thick crystals to pale yellow in massive or   
powdery forms.  
 Luster is vitreous to more often resinous or earthy in massive forms 
 Transparency is transparent to translucent 
 Crystal system is orthorhombic 
 Crystal habits include mostly massive or powdery forms but well shaped blocky     
crystals are common. 
 Cleavage is very poor  
 Fracture is conchoidal 
 Streak is yellow 
 Hardness is 2 
 Specific gravity is 2.0 – 2.1 
 Best Field Indicators are colour, odour, heat sensitivity, lack of good cleavage and 
crystal habit 
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Chemical Properties 
Atomic number  - 16 
Atomic mass   - 32.06g.mol
-1
 
Density   - 2.07g.cm
-3
 at 20ºc 
Melting point   - 113ºc 
Boiling point   - 445ºC 
Isotopes   - 5 
Energy of first ionization - 999.3  kJ.mol
-1 
Energy of second ionization - 2252 kJ.mol
-1 
Energy of third ionization - 3357 kJ.mol
-1 
Standard potential  - -0.51 V 
Sources 
 Sulphur is an essential element for all life, and is widely used in biochemical 
processes. In metabolic reactions, sulphur compounds serve as both fuels (electron donors) 
and respiratory (oxygen-alternative) materials (electron acceptors). 
 The vast majority is produced as a by- product of oil refining and natural gas 
processing. Sulphur is readily available in protein foods- eats, fish, poultry, eggs, milk and 
legumes. Complete vegetarians and people on low- protein diets may not get sufficient 
amounts of sulphur.  
 Many sulphur compounds are odoriferous, and the smell of odorized natural gas, 
skunk scent, grapefruit, and garlic is due to sulfur compounds. Hydrogen sulfide produced 
by living organisms imparts the characteristic odour to rotting eggs and other biological 
processes. 
 Sulphur is an important part of many enzymes and in antioxidant molecules like 
glutathione and thioredoxin. Organically bonded sulphur is a component of all proteins, as 
the amino acidscysteine and methionine.  
 Disulfide bonds are largely responsible for the mechanical strength and insolubility 
of the protein keratin, found in outer skin, hair, and feathers, and the element contributes 
to their pungent odour when burned. 
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Uses 
 It is used in scabies. 
 Joined problems may helped by chondrotin sulphate, which is found high amounts 
in the joint, which is found high in the joint tissues. 
 Magnesium sulphate which is not absorbed is used as a laxative. 
 It is used for treatment of Itchy skin, Psoriasis, Migrane headaches, Indigestion, 
Haemorrhoids, Acne, Eczema, Painful and irregular menstruation. 
 
 
 
  
 
 
Analytical study of 
PATTAI VALLATHAGI 
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5. ANALYTICAL STUDY  OF THE DRUG  PATTAI VALLATHAGI 
          Analytical study  brings the validation to be used as a medicine by subjecting the 
drug to many analysis and determining its quality and effectiveness. Analytical study  
includes many studies such as its organoleptic character physical characteristics and 
phytochemical properties and also to assess the active principles and elements present in 
the drug. Thus Analytical study  brings the efficacy and potency of the drug. 
As per AYUSH protocol for , Analytical study the following parameters were evaluated. 
 
Analytical study of the drug includes: 
 Organoleptic characters 
 Colour 
  Oder 
  Taste 
  Texture 
 
 Physicochemical analysis 
 Determination of Ash Values 
 Physical characterization 
 
 Chemical analysis 
 Preliminary Basic and Acidic radical studies  
 
 Phytochemical analysis 
        HPTLC and TLC 
 
 Heavy metal analysis 
 Microbial analysis 
 Elemental analysis 
Inductively Coupled Plasma Optical  Emissios Spectrometry(ICP- OES) 
 
 Analysis of particle size   
Scanned Electron Microscopy (HR-SEM) 
 
  
 
 
Physico chemical 
analysis 
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5.1 Organoleptic characterization of Pattai vallathagi: 
Colour 
The medicine was taken into watch glasses and placed against white back ground 
in white tube light. It was observed for its colour by naked eye. 
Odour 
The medicine was smelled individually. The time interval among two smelling was 
kept 2 minutes to nullify the effect of previous smelling. 
The results of organoleptic characterization were  showed in table ( 1 )    
5.2 Physicochemical Analysis of Pattai Vallathagi 
Physical properties of Pattai vallathagi 
The physical properties of Pattai vallathagi was analyzed at Captain Srinivasa 
murti Reseach Institute  of Ayurveda and Siddha Drug Development, Arumbakkam, 
Chennai-106. 
pH at 10% of aqueous solution:  
         Five grams of  Pattai vallathagi   was weighed accurately and placed in clear 100 ml 
beaker. Then 50 ml of distilled water was added to it and dissolved well. After 30 minutes 
it was then applied in to pH meter at standard buffer solution of 4.0, 7.0, and 9.2. 
Determination of Ash Values: 
1. Total Ash 
         3gm is accurately weighed and incinerated in a crucible dish at a temperature not 
exceed 450
o
C until free from carbon. It is then cooled and weighed. The % w/w of ash 
with reference to the air-dried powder is calculated. 
2. Acid insoluble Ash 
         The total ash is obtained as the above method for preparation of total ash. The ash is 
boiled for 5minutes with 25ml 10% Hcl. The insoluble ashes is collected using filter paper 
and washed with hot water and then transferred to the silica crucible then ignite for 
15minutes at temperature not exceeding 450
o
C. The silica crucible and residue are 
weighed until constant weight is attained. 
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3. Loss on Drying 
The drug Pattai vallathagi was dried in the oven at 100- 105°C to constant weight.  
4. Determination Of Specific Gravity : 
         Clean a specific gravity bottle by shaking with acetone and then with ether.Dry the 
bottle and note the weight.Cool the sample solution to room temperature.Carefully fill the 
specific gravity bottle with the test liquid and insert the stopper and remove the surplus 
liquid and note the weight.Repeat the procedure using distilled water in place of sample 
solution. 
  Calculation: 
       Specific gravity=weight of test sample held in specific gravity bottle 
                                  Weight of water held in specific gravity bottle 
   
5. Determination of Fat Content : 
          Accurately weight 3-4g of sample into a 500ml beaker.Add slowly while stirring 
45ml of boiling water to give a homogenous suspension.Add 55ml of appr.8 M 
Hydrochloric acid.Cover with watch glass boil gently for 15 minutes.Rinse the watch  
glass with 100ml of water. Filter through Whatman no.42 and continue the washing till the 
filtrate is chloride free. Transfer wet paper and residue to defatted extraction thimble and 
dry in a small beaker at 100˚ C in hot air over.place thimble in Soxhlet.Rinse  digestion 
beaker, drying beaker and watch glass with three 50ml portions of Petroleum ether and 
add washings to thimble.Reflux digested residue for 4 hours.Remove flask and evaporate 
petroleum ether (B.P 40-60˚C ) on steam bath.Dry flask at 100-101˚C to constant 
weight.Cool in a desiccator to room  temperature and weight until constant weight is 
attained.Do the duplicate determination. 
 
  Calculation =Weight of petroleum ether extract  x 100     
                              Weight of the sample taken      
6. Determination of sugar content (Lane Eynon’s method) 
Procedure : 
Preparation of Fehling’s solution :It is prepared by mixing equal volumes of solutions A 
and B. 
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Solution A : Dissolve 34.639g of pure crystallized CuSO4.5 H2O in water and  make up 
to 500ml  
Solution B: Dissolve 173 g of Rochelle salt (Potassium Sodium tartrate, 
KNaC4H4O6.4H2O),50g of Sodium hydroxide in water and make up to 500ml Mix equal 
volumes of A and B just when needed. 
Dissolve 1 g of Methylene blue in 100ml water. 
Methylene blue indicator :Dissolve 1g of Methylene blue in 100ml of water. 
Sample preparation : 
       Take 10 ml/10 g of sample in a 250 ml volumetric flask and add 200 ml water, add 
slight excess solid basic Lead acetate to remove tannins and without disturbing the 
solution make up to the mark.Shake and filter.Add slight excess of solid Sodium oxalate to 
remove excess of basic Lead acetate.This filtrate is used for the estimation of reducing 
sugar. 
6.1 Reducing sugar : Take the suger solution in a 50 ml burette 
Preliminary titration  
        Pipette 10 ml of Fehling „s solution into a 250 ml conical flask, and add from the 
burette,15 ml of the sugar solution.Boil the liquid on asbestos-covered gauze and add 
further quantities of the sugar solution (One ml at a time) at 10 to 15 second intervals to 
the boiling liquid until the blue colour is nearly discharged.Then add 3-5 drops of aqueous 
Methylene blue solution (1%) and continue the titration until the indicator is completely 
decolourised. 
Accurate titration  
        Repeat the titration, adding before heating, almost all of the sugar solution required to 
effect reduction of copper.Boil gently for two minutes,add 3-5 drops of Methylene blue 
indicator and complete the titration within a total boiling time of three minutes.At the end 
point all the blue colour should be discharged and the liquid should be red.The proportions 
of the various sugars,equivalent to 10 ml of Fehling‟s solution are given in the table. 
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6.2 Total sugar   
        Take 20 ml of reducing sugar solution,and add 10 ml of concentrated Hydrochloric 
acid and keep it aside overnight.Neutralise with approximately 1M Sodium hydroxide and 
make up to 100 ml in a volumetric flask.Determine the total sugar content by the 
titrimetric method described above. 
Repeat the experiment twice and take the average value. 
Calculation  
      mg of sugar in 100 ml = Total reducing sugar from table x 100 
                                                                     Titre 
Reducing sugar % = mg of sugar in 100 ml x 250 x 100 
                                       1000 x 100 x10 
Total sugar % = mg of sugar in 100 ml x 250 x 100  x100 
                                      1000 x 100 x 20 x 10 
Results: 
   The results of physico chemical analysis were showed in table ( 2 ) 
 
 
 
 
 
 
 
 
 
  
 
 
Chemical analysis 
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5.3  CHEMICAL ANALYSIS OF  PATTAI  VALLATHAGI 
The  chemical analysis of   PATTAI  VALLATHAGI  was carried out in Bio-
chemistry Lab, National Institute Of Siddha  . 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of extract Light brown  in 
colour 
 
2. Test for Slicate 
a. A 500mg of the sample was shaken 
well with distilled water. 
 
Sparingly soluble 
 
 
Absence of Silicate 
 
 
3. Action of Heat: 
  A 500mg of the sample was taken in 
a dry test tube and heated gently at 
first and then strong. 
No White fumes  
evolved. 
No brown fumes 
evolved. 
 
Absence of 
Carbonate 
 Absence  of Nitrate. 
 
 
 
4. Flame Test: 
  A 500mg of the sample was made 
into a paste with con. HCl in a watch 
glass and introduced into non-
luminous part of the Bunsen flame. 
 
No bluish green 
flame 
 
 
Absense  of copper 
 
 
5. Ash Test:  
A filter paper was soaked into a 
mixture of extract and dil. cobalt 
nitrate solution and introduced into the 
Bunsen flame and ignited. 
 
Appearance of yellow 
colour flame 
 
 
 
 
 
flame 
 
 
 
flame 
 
Absense of sodium 
 
 
 
Preparation of Extract: 
        5gm of Pattai Vallathagi  was taken in a 250ml clean beaker and added with 50ml of 
distilled water. Then it is boiled well for about 10 minutes. Then it is cooled and filtered in 
a 100ml volumetric flask and made up to 100ml with distilled water. This preparation is 
used for the qualitative analysis of acidic/basic radicals and chemical constituents in it. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1. Test For Sulphate: 
a.2 ml of the above prepared extract was taken 
in a test tube to this added 2 ml of 4% dil 
ammonium oxalate solution 
b. 2 ml of the above prepared extract is added 
with 2 ml of diluted HCL is added until the 
effervescence ceases off. Then 2 m of Barium 
Chloride solution is added. 
 
Cloudy 
appearance 
present 
A white 
precipitate 
insoluble in 
con.HCL was 
obtained. 
Presence  of 
Sulphate 
 
Sulphate was 
confirmed 
 
2. Test For Chloride: 
2ml of the above prepared extracts was added 
with 2ml of dil-HCl is added until the 
effervescence ceases off.. 
No cloudy 
appearance 
 
 
Absence of 
Chloride 
 
3 Test for phosphate : 
2ml of the extract were treated with 2 ml of 
dil.ammonium molybdate solution and 2 ml of 
con .HNo3 
No cloudy 
yellow 
appearance 
formed 
Absence of 
phosphate 
4.   
Test For Carbonate: 
2ml of the extract was treated with 2ml             
dil. magnesium sulphate solution 
No cloudy 
appearance. 
 
Absence of  
carbonate 
 
5. Test For Nitrate: 
1gm of the extract was heated with copper 
turning and concentrated H2So4 and viewed the 
test tube vertically down. 
 No Brown gas 
was evolved  
 
 
Absense of nitrate 
 
 
6. Test For Sulphide: 
1gm of the extract was treated with 2ml of con. 
HCL 
 No rotten egg 
smelling gas 
was evolved 
Absence of 
sulphide 
 
7. Test For Fluoride & Oxalate: 
2ml of extract was  added with 2ml of dil. 
Acetic acid and 2ml dil.calcium chloride 
solution and heated. 
 No cloudy 
appearance. 
 
Absence of 
fluoride and 
oxalate 
 
8. 
 
Test For Nitrite: 
3drops of the extract was placed on a filter 
paper, on that-2 drops of dil.acetic acid and 2 
drops of dil.Benzidine solution is placed. 
No 
characteristic 
changes 
 
Absence of nitrite 
 
 
9. Test For Borate: 
50mg of the extract was made into paste by 
using dil.sulphuric acid and alcohol (95%) and 
introduced into the blue flame. 
 bluish green 
colour flame 
not appeared 
Absence  of 
borate 
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II. Test For Basic Radicals 
1. Test For Lead: 
2ml of the extract was added with 2ml of 
dil.potassium iodine solution. 
No Yellow 
precipitate was 
obtained 
 
Absence of lead 
 
2. Test For Copper: 
a. One pinch (25mg) of extract was made into 
paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the 
flame. 
No blue colour 
precipitate 
Absence of    
copper 
3. Test For Aluminium: 
To the 2ml of extract dil.sodium hydroxide was 
added in 5 drops to excess. 
Shows 
characteristic 
changes 
 
 
 
 
 
 
 
 
 
characteristic 
changes chara 
Absence of    
Aluminium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Test For Iron: 
a. To the 2ml of extract add 2ml of 
dil.ammonium solution 
b. To the 2ml of extract 2ml  thiocyanate 
solution and 2ml  of con HNo3 is added 
Mild Red colour 
appeared 
 
 
Presence of 
Iron 
 
 
 
5. Test For Zinc:  
To 2ml of the extract dil.sodium hydroxide 
solution was added in 5 drops to excess and dil 
.ammonium chloride is added.  
NoWhite 
precipitate was 
formed 
Absence of 
Zinc 
6. Test For Calcium:  
2ml of the extract was added with 2ml of 4% 
dil.ammonium oxalate solution  
Cloudy 
appearance and 
white precipitate 
was formed 
Presence of 
calcium 
 
 
 7. Test For Magnesium:  
To 2ml of extract dil.sodium hydroxide solution 
was  added in drops to excess. 
No  White 
precipitate  was 
obtained 
 
Absence of 
magnesium 
 
 
8. Test For Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent and 
excess of dil.sodium hydroxide solution are 
added. 
No Light Brown 
colour appeared 
 
Absence of 
ammonium 
 
 
9. Test For Potassium: 
A pinch (25mg) of extract was treated of with 
2ml of dil.sodium nitrite solution and then 
treated with 2ml of dil.cobalt nitrate in 30% dil. 
glacial acetic acid. 
Yellow 
precipitate  was 
obtained 
 
Presence of 
potassium 
10. Test For Sodium: 
2 pinches (50mg) of the extract is made into 
paste by using HCl and introduced into the blue 
flame of Bunsen burner. 
No yellow 
colour flame 
evolved. 
 
 
 
 
 
 
 
 
 
 
 
Absence of 
sodium 
 
 
11. Test For Mercury: 
2ml of the extract was treated with 2ml of dil. 
sodium hydroxide solution. 
No Yellow 
precipitate was 
obtained 
 
Absence of 
Mercury 
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12. Test For Arsenic: 
2ml of the extract was treated with 2ml of 
dil.sodium hydroxide solution. 
No  Brownish 
red precipitate  
was obtained 
Absence of 
arsenic 
 
III. Miscellaneous 
1. Test For Starch: 
2ml of extract was treated with weak dil.Iodine 
solution 
Blue colour 
developed 
Presence of 
starch 
2. Test For Reducing Sugar: 
5ml of Benedict's qualitative solution was taken in 
a test tube and allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract and again boil it 
for 2 minutes. The colour changes are noted. 
No Brick red 
colour was  
developed 
 
Absence of  
reducing sugar 
 
 
3. Test For The Alkaloids: 
a) 2ml of the extract was treated with 2ml of 
dil.potassium lodide solution. 
b)  2ml of the extract was treated with 2ml of 
dil.picric acid. 
c)  2ml of the extract was treated with 2ml of 
dil.phosphotungstic acid. 
 
 
No red colour 
developed 
 
 
Presence 
of Alkaloid 
 
 
4. Test For Tannic Acid: 
2ml of extract was treated with 2ml of dil.ferric 
chloride solution 
Blue-black 
precipitate  
was obtained 
presence of 
Tannic acid 
 
5. Test For Unsaturated Compound: 
To the 2ml of extract 2ml of dil.Potassium 
permanganate solution is added. 
Potassium 
permanganate 
is not 
decolourised 
Absence of 
unsaturated 
compound 
 
6. Test For Amino Acid: 
2 drops of the extract was placed on a filter paper 
and dried well. 20ml of Burette reagent is added. 
No violet 
colour 
 
Absence of amino 
Acid 
7. Test For Type Of Compound: 
2ml of the extract was treated with 2 ml of 
dil.ferric chloride solution. 
No green and 
red colour 
 
 
 
 
No Violet 
colour 
developed 
 
 
 
 
No Blue colour 
developed. 
Absence of 
quinolepinephrine 
pyrocatecho 
antipyrine 
 
Aliphatic amino 
acid and meconic 
acid. 
Apomorphine 
salicylate and 
Resorcinol are 
absent 
 
Morphine, Phenol 
cresol and 
hydrouinone are 
present. 
Results: 
 The  results of acid and basic radicals were showed in tables  ( 3-5 ) 
  
 
 
Tlc/hptlc finger print 
Analysis 
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5.4  TLC/HPTLC FINGER PRINT ANALYSIS 
    
Thin layer chromatography (TLC) is a chromatographic technique used to separate 
the components of a mixture using a thin stationary phase supported by an inert backing. It 
may be performed on the analytical scale as a means of monitoring the progress of a 
reaction, or on the preparative scale to purify small amounts of a compound. 
 TLC/HPTLC is an analytical tool widely used because of its simplicity, relative 
low cost, high sensitivity, and speed of separation. TLC/HPTLC functions on the same 
principle as all chromatography: a compound will have different affinities for the mobile 
and stationary phases, and this affects the speed at which it migrates. The goal of 
TLC/HPTLC is to obtain well defined, well separated spots. 
Retention Factor 
After a separation was complete, individual compounds appear as spots separated 
vertically. Each spot has a retention factor (Rf) which is equal to the distance migrated 
over the total distance covered by the solvent. The Rf formula is 
Rf  = distance traveled by sample /distance traveled by solvent 
The Rf value can be used to identify compounds due to their uniqueness to each 
compound.  When comparing two different compounds under the same conditions. 
The compound with the larger Rf value is less polar because it does not stick to the 
stationary phase as long as the polar compound, which would have a lower Rf value 
 
 
 
 
 
 
  
 
 
 
HEAVY  METAL  ANALYSIS 
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5.5  HEAVY METAL ANALYSIS 
    The procedure recommended for analysis of  Heavy Metals like Lead and 
Cadmium in WHO, 1998 and AOAC, 2005.
 (20)
 
INSTRUMENT DETAILS: 
    Thermo Fisher M  Series, 650902 V1.27 model Atomic Absorption Spectometer (AAS) 
was used  for the analysis. The operating parameters: 
Lead and Cadmium: 
Instrument technique            :   Flame technique 
Wavelengt (Lead)                 :  217 nm 
Wavelengt (Cadmium)         :  228.8 nm 
Slit width                              : 0.5 mm  
Lamp current (Pb)                : 4.0 mA  
Lamp current (Cd)                : 3.0 mA 
Carrier gas and flow rate      :   Air and Acetylene, 1.1 L/min 
 
Mercury:  
Instrument technique  : Cold vapour technique 
Wavelength    : 253.7 nm 
Slit width    : 0. 5 mm 
 Lamp current              : 3.0 mA,  
Carrier gas and flow rate : Argon, 1.1 L/min 
Flow rate   : 5ml/min 
 
Arsenic:  
Instrument technique  : Flame vapour technique 
Wavelength    : 193.7 nm 
Slit width    : 0. 5 mm 
 Lamp current    : 6.0 mA,  
Carrier gas and flow rate : Acetylene, Argon, 1.1 L/min 
Flow rate   : 5ml/min 
The Hallow cathode lamp for Pb, Cd, Hg and As analysis were used as light source 
to provide specific wavelength for the elements to be determined. 
Result :    The results of heavy metals  were  showed in table ( 7 )    
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5.6  Microbial Analysis:  
           Microbial analysis was carried for determination of microbial contamination as per 
procedures of Indian pharmacopoeia  2010 and WHO Guideline . The test included total 
bacterial count, total fungal count, identification of specified organisms such as 
Escherichia coli, Salmonella sp., Staphylococcus aureus and Enterobacteriaceae,  
Result : 
      The results of microbial analysis  were  showed in table ( 8 )    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Elemental 
analysis 
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5.7 ELEMENTAL  ANALYSIS 
 The analysis of heavy metals and trace elements were estimated by using 
Inductively coupled plasma optical emission spectrometry (ICP- OES). The Experimental 
Procedure was done at SAIF, IIT Madras, Chennai-36. 
 INDUCTIVELY COUPLED PLASMA OPTICAL EMISSIOS  SPECTROMETRY 
(ICP-OES ) 
Introduction 
         The element composition of a sample is often an important part of the information 
needed to assess its properties. Hence there is a need for scientific instrumentation like 
ICP-OES which plays a pivotal role in the determination of these elements. ICP-OES is 
widely employed for the estimation of metals and  metallolids at trace, minor and major 
concentration. 
Principle  
        In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons. The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer , so that intension of the individual wavelength can 
be measured . the number of photos emitted is directly proportional to the concentration of 
the element.  The photos may be detected either sequentially or simultaneously. 
Quantitative analysis is achieved by measuring the intensity of these specific wavelength 
and after performing the calibration using known standards. 
       Identifying the presence of emission at the wavelength characteristic of the element of 
interest obtaining quantitative information i.e, how much of an element is in sample can be 
accomplished using plots of emission intensity versus concentration called calibration 
curves. 
Sample preparation – Microwave Digestion 
 Weight 0.25 g of test sample and transfer into a liner provided with instrument. 
 Slowly add 9ml of Nitric acid or sulphuric acid such that no piece of sample sticks 
on the slide. 
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 Mix thoroughly and allow reacting for  few minutes. 
 Place the liner in the vessel jacket. 
 Close the screw cap hand- tight in clockwise direction. 
 Seal the vessel and placed in the rotor fixed in microwave. 
 Set temperature to 180°C for 5 minutes, hold at 180°C  for least 10 minutes.                                                                                                                                                           
Allow the vessels to cool down to a vessel interior temperature below 60°C and to 
a vessel surface temperature (IR) below 50°C before removing the rotor. 
 The digested sample was made upto 100ml  with Millipore water. 
 If visible insoluble particles exist, solution could be filtered through whatmann 
filter paper. 
 Transfer the digested solution into plastic containers and label them properly. 
Perkin Elmer Optima 5300DV was used for standard ICP-OES analysis. The 
optimized operating conditions are given in table 1,   and the test Pattai Vallathagi  
underwent microwave digestion for sample preparation.  
Result : 
      The results of elemental analysis  were  showed in table ( 9 )    
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
PARTICLE SIZE ANALYSIS 
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5.8   ANALYSIS OF PARTICAL SIZE 
SCANNED ELECTRON MICROSCOPY (SEM) 
The partical size of the Pattai Vallathagi was determined using High resolution 
scanning electron microscopy (HR SEM). The Experimental Procedure was done at SAIF, 
IIT Madras, Chennai-36. 
Experimental procedure : 
              A SEM is essentially a high magnification microscope, which uses a focused 
scanned electron beam to produce images of the sample, both top-down and, with  the 
necessary sample preparation, cross-sections. The primary electron beam interacts with  
the sample in a number of key ways :- 
 Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic  nature of the specimen. 
 Primary electrons can be backscattered which produces images with a high degree 
of atomic number (Z) contrast. 
 Ionized atoms can relax by electron shell-to-shell transitions, which lead to either 
X-ray emission or Auger electron ejection.The X-ray emitted are characteristic of 
the elements in the top few  µm of the  sample. 
The SEM is carried out by using FEI Quanta FEG 200-High Resolution Instrument. 
Resolution   :   1.2 nm gold particle separation on a carbon substrate 
Magnification :   From a min of 12 X to greater than 1,00,000 X. 
Method : 
          A representative portion of each sample was sprinkled on to a double side carbon 
tape and mounted on aluminium stubs, in order to get a higher quality secondary electron 
image for  SEM examination. 
Sample preparation : 
       Sample preparation can be minimal or elaborate for SEM analysis, depending on  the 
nature of the  samples and the  data required. Minimal preparation includes acquisition of 
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a sample that will fit into the SEM chamber and some accommodation to prevent charge 
build-up on electrically insulating samples. 
 Calculation of the particle size: 
         The horizontal line in the right corner of the micrograph corresponds to micron in 
length would be given. A comparison could be made between the length of the particles 
visible in the micrograph with this line and the length of the particle was calculated 
 
Result : 
      The results of particle size  were  showed in fig ( 1 )    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Toxicological studies 
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6. TOXICOLOGICAL EVALUATION OF PATTAI  VALLATHAGI 
IN RODENTS 
Introduction: 
Safety is a fundamental principle in the provision of traditional medicines and 
herbal products for health care and a critical component of quality control. OECD 
guidelines provide practical and technical guidance for monitoring the safety of traditional 
medicines within pharmacovigilance systems. The safety monitoring of traditional 
medicines is compared and contrasted with that of other medicines, currently undertaken 
in the context of the WHO International Drug perspective. 
Scope of work:  
Monitoring Programme, while there are regulatory and cultural differences in the 
preparation and use of different types of medicines, they are all equally important from a 
pharmacovigilance 
Assurance of safety, quality and efficacy of Indian System of Medicines (ISM) is 
the key issue that needs to be addressed while conducting toxicity studies. It is an essential 
step, which will strengthen the acceptance of Siddha medicines by scientific community. 
Information of toxicity and adverse effects of these formulations are lacking. Some of the 
formulations are proved to be effective in various animal studies and many more are yet to 
be tested.  
Hence, the present study was carried out to evaluate the Preclinical animal toxicity 
studies of  PATTAI VALLATHAGI  in rodents.  
Plan of work: 
The following studies were carried out on PATTAI VALLATHAGI 
 Acute oral toxicity – OECD 423 
  Repeated  dose 28 day oral toxicity study – OECD 407 
 Reapted dose 90 days oral toxicity study-OECD 408 
 
 
  
 
 
ACUTE TOXICITY STUDY 
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6.1 ACUTE ORAL TOXICITY STUDY OF PATTAI VALLATHAGI 
(OECD GUIDELINE - 423) 
Aim :  
 To evaluate the acute and sub acute sub chronic toxicities of siddha drug “Pattai 
Vallathagi” in wistar albino rats. The drug  Pattai Vallathagi was prepared by the method 
prescribed in standard text books of siddha medicine. 
 experiment procedure:  
         Acute toxicity study was carried out according to the OECD (Organization of 
Economic Co-operation and Development) guidelines 423. Healthy female rats, weighing 
150–200 g, were selected and oral administration of the single doses of Pattai Vallathagi  
were done aseptically by  water. 
Experimental animals: 
          Albino rats (wistar rats) of either sex weighing (150-200 g) were procured from 
animal housing facility, K.K college of pharmacy, Gerugambakkam, Chennai. All animals 
were placed in a polypropylene cages in a controlled room temperature 24 ̊  C±1̊  C and 
relative humidity of 60-70 % in animal house. The animals were maintained in standard 
pellet diet and water ad libitum .They were acclimatized to laboratory condition for seven 
days before commencement of the experiment. 
         All the protocols and the experiments conducted in strict compliance according to 
ethical principles and guidelines provided by committee for the purpose of control and 
Supervision of Experiments on Animals (KKCP/2015/026-).Animal experimentation 
protocols are approved by Institutional Animal Ethical Committee. 
 Administration of doses:  
          Pattai Vallathagi  was administered as a single oral dose by gavage using a feeding 
needle. Animals were fasted prior to dosing. Following the period of fasting, the animals 
were weighed and then the test substance was administered. After the substance has been 
administered, food was withheld for further 3-4 hours. The principle of laboratory animal 
care was followed. Observations were made and recorded systematically and continuously 
observed as per the guideline after substance administration. 
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          An oral (p.o) dose of 5 mg/kg, 50 mg/kg, 300 mg/kg and 2000 mg/kg was 
administered step by step according to the guidelines. The general behaviors of the rats 
were continuously monitored for 1 h after dosing, periodically during the first 24 h (with 
special attention given during the first 4 hours and then daily thereafter, for a total of 14 
days. Changes in the normal psychomotor activity and external morphology and their body 
weights were monitored periodically before dosing and the time at which signs of toxicity 
or mortality were recorded. 
          The visual observations included skin changes, morbidity, aggressiveness, 
sensitivity to sound and pain, as well as respiratory movements were recorded. They were 
deprived of food, but not water 12 h prior to the administration of the test substance. 
Finally, the number of survivors was noted after 24 h and these animals were then 
maintained for a further 14 days and observations made daily. The toxicological effect was 
assessed on the basis of mortality.  
 
Test Substance : Pattai Vallathagi  
Animal Source  : Animal house of King Institute of Preventive Medicine 
Animals : Male and Female Wistar Albino Rats  
Age  : More than 8 weeks 
Acclimatization : Seven days prior to dosing. 
Veterinary examination : Prior to and at the end of the acclimatization period. 
Identification of 
animals 
: By cage number, animal number and individual marking on 
fur. 
Diet : Pelleted feed supplied by Godrej foods Pvt Ltd, Bangalore 
Water  : Potable water in polypropylene bottles ad libitum. 
Housing & 
Environment 
: The animals were housed in Polypropylene cages provided 
with bedding of husk. 
Housing temperature : Between 20 & 24°C,  
Relative humidity : Between 30% and 70%, 
Dark and light cycle : Each of 12 hours. 
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Number of animals and dose levels:  
         Three animals were used for each step. The dose level used as the starting dose was 
selected from one of four fixed levels, 5, 50, 300 and 2000 mg/kg body weight. The 
starting dose level was most likely to produce mortality in some of the dosed animals. The 
available information suggests that mortality is likely at the highest starting dose level 
2000mg/kg body weight, so the trial or limit test was conducted. The time interval 
between treatment groups is determined by the onset, duration and severity of toxic signs.  
OBSERVATIONS:  
        Animals were observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours, and daily thereafter, for a total period of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found dead. 
It should be determined by the toxic reactions, time of onset and length of recovery period, 
and may thus be extended when considered necessary. The times at which signs of toxicity 
appear and disappear are important, especially if there is a tendency for toxic signs to be 
delayed. 
         All observations were systematically recorded with individual records being 
maintained for each animal. Observations include changes in skin and fur, eyes and 
mucous membranes, and also respiratory, circulatory, autonomic and central nervous 
systems, and somato motor activity and behavior pattern. Attention was directed to 
observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma. The 
principles and criteria summarized in the Humane Endpoints Guidance Document taken 
into consideration. Animals found in a moribund condition and animals showing severe 
pain or enduring signs of severe distress was humanely killed. When animals are killed for 
humane reasons or found dead, the time of death should was recorded. From the maximum 
dose 1\5th or 1\10th of the dose was considered as therapeutic dose for further study 
   Results : 
                All date were summarized in table (10)                                           
    
 
  
 
 
Repeated DOSE 28 DAYs 
oral toxicity study 
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6.2  REPEATED DOSE 28 DAYS ORAL TOXICITY STUDY OF  
PATTAI VALLATHAGI (OECD GUIDELINE - 408) 
experiment procedure:  
           Sub-acute toxicity study was carried out according to OECD 407 and rats were 
divided into 3 groups of 10 animals (5 male and 5 female). Pattai Vallathagi was 
administered to rats at the dose of   900mg /kg  and 1800mg/kg continuously for 28 days. 
The animals were observed daily for gross behavioural changes and other sign of sub 
acute toxicity. The weight of the each rat was recorded on day 0 and weekly throughout 
the course of the study, Food and water consumption per rat was calculated. At the end of 
28 days they were fasted overnight ,each animal were anaesthetized with diethyl ether  and 
blood samples were collected from the retro-orbital plexus into two tubes: one with EDTA 
for immediate analysis of haematological parameters, the other without any anticoagulant 
and was centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain the serum. Serum was 
stored at 20 °C until analyzed for biochemical parameters. 
 
Test Substance : Pattai Vallathagi  
Animal Source  : Animal house of King Institute of Preventive Medicine 
Animals : Male and Female Wistar Albino Rats  
Age  : More than 8 weeks 
Acclimatization : Seven days prior to dosing. 
Veterinary examination : Prior to and at the end of the acclimatization period. 
Identification of 
animals 
: By cage number, animal number and individual marking on 
fur. 
Diet : Pelleted feed supplied by Godrej foods Pvt Ltd, Bangalore 
Water  : Potable water in polypropylene bottles ad libitum. 
Housing & 
Environment 
: The animals were housed in Polypropylene cages provided 
with bedding of husk. 
Housing temperature : Between 20 & 24°C,  
Relative humidity : Between 30% and 70%, 
Dark and light cycle  
Duration of  study 
: Each of 12 hours. 
 28 days 
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Justification for Dose Selection: 
 The results of acute toxicity study in rats indicated that Pattai Vallathagi   was  
non toxic and no behavioral changes was observed up to the dose level of 2000mg/kg 
body weight. The oral route was selected for use because oral route is considered to be a 
proposed therapeutic route. 
Preparation and administration of dose:  
          Pattai Vallathagi at two doses level 900mg/kg and 1800mg/kg respectively were 
prepared.. The test substance were freshly prepared every day for 28 days. The control 
animals were administered vehicle only. Administration was by oral (gavage), once daily 
for 28 consecutive days. 
METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
 Ten Rats (Five Male and Five Female) in each group randomly divided into three 
groups for dosing up to 28 days. Animal‟s acclimatization period of 7 days to laboratory 
conditions prior to the initiation of treatment. Each animal was fur marked with picric 
acid. The females were nulliporous and non-pregnant. 
OBSERVATIONS: 
Experimental animals were kept under observation throughout the course of study for the 
following: 
i)Body Weight: 
Weight of each rat was recorded on day 0 at weekly  intervals throughout the course of 
study and at termination to calculate relative organ weights. From the data, group mean 
body weights and percent body weight gain were calculated table (11 )table (19 ) 
 ii) Food and water Consumption:  
The quantity of food consumed by groups consisting of ten animals of for different 
doses was recorded at weekly interval. Food consumed per animal was calculated for 
control and the treated dose groups tables (12,13 ) 
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iii)Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
iv)Mortality:  
All animals were observed twice daily for mortality during entire course of study. 
v)Laboratory investigation: 
           Following laboratory investigations were carried out on day 29 in animals fasted 
over-night. On 29th day, the animals were fasted for approximately 18 h, then anesthetized 
with ether and blood samples were collected from the retro-orbital plexus into two tubes: 
one with EDTA for immediate analysis of haematological parameters, the other without 
any anticoagulant and was centrifuged at 4000 rpm at 4 °C for 10 minutes to obtain the 
serum. Serum was stored at 20 °C until analyzed for biochemical parameters. 
Haematological Investigations:  
          Blood samples of control and experimental rats were analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count, Mean 
corpuscular volume (MCV) and packed cell volume (PCV). From the estimated values of 
RBC count (millions/mm3) and PCV (volumes percent), mean corpuscular volume (MCV) 
was calculated.  
Biochemical Investigations:  
Serum and Urine was used for the estimation of biochemical parameters. Samples 
of control and experimental rats were analyzed for protein, bilirubin, urea, uric acid, 
creatinine, triglyceride, cholesterol and glucose levels by using standard methods. 
Activities of glutamate oxaloacetate transaminase/ Aspartate aminotransferase 
(GOT/AST), glutamate pyruvate transaminase/ Alanine amino transferase (GPT/ALT) and 
alkaline phosphatase were estimated as per the colorimetric procedure.  
 
Necropsy:  
All the animals were sacrificed on day 29. Necropsy of all animals were carried out 
and the weights of the organs including liver, kidneys, adrenals, spleen, brain, heart, uterus 
and testes/ovaries were recorded. The relative organ weight of each animal was then 
calculated as follows; 
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Absolute organ weight (g) 
Relative organ weight = ____________________________________________ ×100 
    Body weight of rats on sacrifice day (g) 
 
Histopathsology:   
           Histopathological investigation of the vital organs were done. The organ pieces(3-
5µm thick) of the highest dose level of 400mg /kg were preserved and were fixed in 10% 
formalin for 24 h and washed in running water for 24 h. Samples were dehydrated in an 
auto technic on and then cleared in benzene to remove absolute alcohol.  Embedding was 
done by passing the cleared samples through three cups containing molten paraffin at 
50°C and then in a cubical block of paraffin made by the “L” moulds. It was followed by 
microtome and the slides were stained with Haematoxylin-eosin.   
The organs included  heart, kidneys, liver ,Spleen, Brain of the animals were 
preserved they were subjected to histopathological examination. 
 
Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way Anova  
Followed by Dunnet‟t‟ test using a computer software programme. (Graph Pad Prism 5.0) 
Result : 
All data were summarized in tabular form  ( Table 14-18  )
  
 
 
REPEATED DOSE 90 DAYS 
ORAL TOXICITY STUDY 
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6.3    REPEATED DOSE  90 DAYS ORAL TOXICITY STUDY OF 
PATTAI VALLATHAGI (OECD GUIDELINE - 408)  
Test Substance  :  PATTAI VALLATHAGI  
Animal Source  :  Animal house of King Institute of Preventive Medicine    
Animals    :  Wister Albino Rats (Male -3, and Female-3) 
Age     :  6-8 weeks 
Body Weight                :  150-200gm. 
Acclimatization   :  Seven days prior to dosing. 
Veterinary examination  :  Prior and at the end of the acclimatization period. 
Identification of animals       :  By cage number, animal number   and    individual     
                                                     marking    by  using Picric acid. 
Diet    :  Pellet feed supplied by Sai meera foods Pvt Ltd,       
     Bangalore 
Water    :  Aqua guard portable water in polypropylene bottles. 
Housing & Environment :  The animals were housed in Polypropylene cages  
                provided with bedding of husk. 
Housing temperature :   between 22ºC + 3ºC.    
Relative humidity  :   between 30% and 70%, 
Air changes    :  10 to 15 per hour  
Dark and light cycle   :  12:12 hours. 
Duration of the study :  90 Days. 
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METHODOLOGY 
Randomization, Numbering and Grouping of Animals: 
24 Wistar Albino Rats (12M + 12F) were selected and divided into 4 groups. Each 
group consist of 6 animals (Male -3, and Female-3) (IAEC  Approval no NIS/IAEC-
I/2016/01).Ist group treated as a control and other three group were treated with test drug 
(low, mid, high) for  90 days. Animals were allowed acclimatization period of 7 days to 
laboratory conditions prior to the initiation of treatment. Each animal was marked with picric 
acid. The females were nulliparous and non-pregnant. 
Justification for Dose Selection: 
        As per OECD guideline three dose levels were selected for the study.They were low 
dose (X), mid dose dose (5X), high dose (10X). X is calculated by multiplying the therapeutic 
dose  and the body surface area of the rat (0.018). i.e X dose is 180 mg/kg, 5X dose is900 
mg/kg,10X dose is  1800mg/kg. 
Preparation and Administration of Dose: 
          Pattai vallathagi was suspended  with distilled water to obtain concentrations of 
200mg/ml. It was administered to animals at the dose levels of X, 5X, 10X. The test 
substance suspensions were freshly prepared every two days once for 90 days. The control 
animals were administered vehicle only. The drug was administered orally by using oral 
gavage once daily for 90 consecutive days. 
OBSERVATIONS: 
Experimental animals were kept under observation throughout the course of 
study for the following: 
 Body Weight: 
 Weight of each rat was recorded on day 0, at weekly intervals throughout the course 
of study. (Table -20) 
 Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity and 
duration of these symptoms, if any, were recorded. 
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 Mortality: 
All animals were observed twice daily for mortality during entire course of   study. 
 Laboratory Investigations: 
         Following laboratory investigations were carried out on day 91 in animals‟fasted 
over-night. Blood samples were collected from orbital sinus using sodium heparin 
(200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for Haematology as 
anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 minutes. 
 Haematological Investigations: 
               Haematological parameters were determined using Haematology analyzer.  
 Biochemical Investigations:  
              Biochemical parameters were determined using auto-analyzer. 
 Histopathology:  
              Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group than 
the low, then the mid dose group will also be examined. Organs will be collected from all 
animals and preserved in 10% buffered neutral formalin for 24 h and washed in running 
water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in an auto 
technic  on and then cleared in benzene to remove absolute alcohol. Embedding was done 
by passing the cleared samples through three cups containing molten paraffin at 50°C and 
then in a cubical block of paraffin made by the “L” moulds. It was followed by 
microtome and the slides were stained with Haematoxylin-eosin. 
 Statistical analysis:  
 Findings such as clinical signs of intoxication, body weight changes, haematology 
and blood chemistry were subjected to One-way ANOVA followed by dunnet‟t‟test using 
a computer software programme -INSTAT-V3 version. 
          Result : 
All data were summarized in tabular form  ( Table 21-25  )
 
 
  
 
 
Anti-inflammatory 
Activity 
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7.1 ANTI-INFLAMMMATORY ACTIVITY OF PATTAI VALLATHAGI       
IN WISTER ALBINO RATS 
AIM: 
        To evaluate the anti - inflammatory activity of Pattai Vallathagi in Wistar albino rats by 
Cotton pellet granuloma method. 
 Selection of Experimental animals: 
       The experimental protocol was submitted and approved by institutional Ethical 
Committee, (IAEC approval No KKCP/2015/026 ). Wistar albino rats  ( 150- 200 gm ) of 
approximate same age were employed in this investigation. The animals were obtained from 
animal house, K.K college of pharmacy, Gerugambakkam, Chennai. Animals were housed at 
a temperature of 24±2˚C and relative humidity of 30-70% at 12 :12 light, day cycle was 
followed. All the animals were allowed to free access to water and fed with standard 
commercial pellet.  
 
Experimental Design for Cotton pellet granuloma  model 
 The animals were divided into four groups each group consists of 6 animals. 
 
Group-I :   Control -  control received distilled water  (dose: 10 ml/kg). 
Group-II :   Standard drug - Animals treated with Dexamethasone (dose: 0.5 mg/kg). 
Group-III :  Animals treated with Pattai Vallathagi ( 200 mg/kg). 
Group-IV :  Animals treated with Pattai Vallathagi ( 400 mg/kg) 
Experimental procedure 
          Inflammation was induced by cotton pellet granuloma model. This method was  carried 
out by using sterilized cotton pellet implantation method in rats. Under light ether anesthesia 
by using blunted forceps, subcutaneous tunnel was made and sterilized cotton pellets (10 ± 1 
mg) were implanted in the axilla and groin region of the rat. After recovering from 
anaesthesia, animals were treated orally with vehicle control (Distilled water 10 ml / kg), 
Dexamethasone 0.5 mg/kg, low dose (200mg/kg) and high dose (400mg/kg) of Pattai 
Vallathagi  for consecutive 7 days, once per day. They were sacrificed on day 8th by cervical 
dislocation and the pellets were removed and immediately the wet weight was taken, freed 
from extraneous tissue and dried at 600C for 24 hrs. The percentage inhibition of  wet weight 
and dry weight of the granuloma were calculated and compared. 
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Control  - Treated                                                                                                                                                                                                     
Percentage inhibition  (%)  = ___________________________ ×100 
                                                               Control     
Statistical analysis 
             Results were expressed as mean ± SEM and analyzed using Graph Pad Prism 
software. One way analysis of variance (ANOVA) test was applied.  
 
Result : 
               Results of anti inflammatory activity by cotton pellet granuloma method showed in 
table (26) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Analgesic activity 
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7.2 ANALGESIC ACTIVITY OF PATTAI VALLATHAGI IN                                       
SWISS ALBINO MICE 
 
AIM: 
          
To evaluate the Analgesic activity of Pattai Vallathagi in Swiss  albino mice by 
Eddy’s Hot plate method. 
 
 Selection of Experimental animals: 
          Healthy Swiss albino mice of either sex weighing (20-25gms) were used for this study. 
The animals were obtained from animal house, K.K college of pharmacy, Gerugambakkam, 
Chennai. Animals were housed at a temperature of 24±2c and relative humidity of 30-70%. 
At 12 :12 light, day cycle was followed. All the animals were allowed to free access to water 
and fed with standard commercial pellet. All the experimental procedures and protocols used 
in this study were reviewed by (IAEC) InstitutionalAnimal Ethics Committee  KKCP/20/026 
of K.K college of Pharmacy and were in accordance with the guidelines of the IAEC. 
Evaluation of Analgesic activity 
          Pain is the part of a defensive reaction against dysfunction of an organ or imbalance in 
its functions against potentially dangerous stimulus. The ascending pathway of pain includes 
the contralateral spinothalamic tract, lateral pons, mid brain to thalamus and ultimately 
through the somatosensory cortex of the brain that determines the locations, intensity and 
depth of pain 
 
Eddy’s Hot plate method: 
Principle: 
         Painful reactions can be produced in experimental animals by applying noxious stimuli 
such as thermal – using radiant heat as a source of pain, chemical  – using irritants such as 
acetic acid and bradykinin and physical pressure  – using tail compression.  
         The hot plate test is a test of the pain response in animals. It is used in basic pain 
research and in testing the effectiveness of analgesics by observing the reaction to pain 
caused by heat. 
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         They used a behavioral model of nociception where behaviors such as jumping and hind 
paw-licking are elicited following a noxious thermal stimulus. Licking is a rapid response to 
painful thermal stimuli that is a direct indicator of nociceptive threshold. Jumping represents 
a more elaborated response, with a latency and encompasses an emotional component of 
escaping. 
Animals 
Mice 20-25 g were grouped in four groups, six animals in each group. 
Grouping: 
Group I  : Control - distilled water (10ml/kg, p.o.),   
Group II  : Standard drug - Pentazocine (5mg/kg, p.o.)  
Group III :          Received   Pattai Vallathagi  (200mg/kg) 
Group IV : Received  Pattai Vallathagi (400mg/kg) 
Equipment: 
 Eddy‟s Hot plate 
 
Procedure: 
          Animals were weighed and placed on the hot plate. Temperature of the hot plate was 
maintained at 55±1 ͦ  C. Jumping response was seen. The time period (latency period), from 
when the animals were placed and until the responses occurred, were recorded using a 
stopwatch. To avoid tissue damage of the animals 10 seconds was kept as a cut off time.  The 
time obtained was considered the basal / normal reaction time in all the untreated groups of 
animals. Increase in the basal reaction time was the index of analgesia. All the animals were 
screened initially at least three times in this way and the animals showing a large range of 
variation in the basal reaction time were excluded from the study. A final reading of the basal 
reaction time was recorded for the included animals. After selecting the animals, the drugs 
were administered to all the groups at the stipulated doses. The reaction times of the animals 
were then noted at  0, 30 , 60 ,90 ,120 and 150 mins  interval after drug administration. 
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Statistical analysis 
      Results were expressed as mean ± SEM and analyzed using Graph Pad Prism software. 
One way analysis of variance (ANOVA) test was applied.  
Result  : 
 The results of analgesic activity by Eddy‟s Hot plate method was represented in table ( 27 )  
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7.3 ANTI-HISTAMINE ACTIVITY OF PATTAI VALLATHAGI IN       
GUINEA PIG 
Experimental animals 
           Guinea pig weighing 400-450g were procured from the animal house in K.K college 
of pharmacy . They were fed with food and water ad libitium. The animals were acclimatized 
for atleast one week in lab condition before commencement of the experiment in 
standardlaboratory conditions 12 ± 01 hour day and night cycle, maintained at 25 ± 30C and 
40 to 60% humidity. The animal protocol was approved by the Institutional Animal Ethics 
Committeewith approval number; IAEC-KKCP/2015/026. 
 
Experimental methods(Isolated guinea pig ileum preparation) 
Procedure: 
Preparation of test drug and Histamine 
         Test drug was dissolved in distilled water and desired concentration was prepared. 
Histamine was dissolved in physiological saline. Physiological saline was widely 
recommended as it is known to be compatible with human tissue, and isotonicity with body 
fluids. 
 
Anti histaminic activity: (Effect of test drug on the guinea pig ileum preparation:- 
          To assess the antihistaminic activity of the test drug, the experiment was carried out on 
isolated guinea pig ileum  Overnight fasted guinea pig was stunned by head blow, neck 
vessels cut and the animal is cut open. Abdomen was opened through a midline incision, the 
ileocaecal junction exposed; the terminal ileum was cut after discarding 10cm nearest to the 
ileocaecal junction. Isolatedileum was placed on a petri dish containing Tyrode solution(Nacl 
8.0, Kcl- 0.2, Cacl2-0.2, Mgcl2 -0.1, NaHCO3 -1.0, NaH2PO4 -0.05 and Glucose-1.0gmper 
liter) at37°C. A 2.5 cm long piece of the distal part of the ileum was used for the study. 
Experiments were performed in organ bath containing  Tyrode solution at 37°C and bubbled 
with Oxygen(air,O2, or 5% CO2 in O2 used for mammalian smooth muscles). The responses 
were recorded on  kymograph paper with frontal writing lever having a 4-7 magnification and 
0.5gm  initial tension. The preparation was allowed to equilibrate for 30 -45 min ,increasing 
concentration of histamine  was recorded with a contact time of 90 seconds. .The test drug 
Pattai Vallathagi were added to the reservoir and same doses of histamine were repeated in 
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the presence of pattaivallathagi. Then the standard drug chlorphenaraminemaleate(10µg/ml) 
was added and the same procedure was repeated .Responses to histamine were recorded as 
changes in height from baseline and expressed as percent of maximum response of the 
histamine. The CRC was constructed with a 20min rest between each. The mean maximal 
response obtained from the first concentration response curve was taken as the 100% 
response. 
Statistical analysis: 
The data was analyzed by one way ANOVA followed by dunnet test. 
Results :  
      The results of Anti- histamine activity by ileum cut terminal  method was represented in 
table ( 28)  
 
 
 
                              
 
 
 
 
 
 
 
 
  
 
 
Results 
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8. RESULT 
5.1 ORGANOLEPTIC CHARACTER
* 
Table:1. Organoleptic characters of  Pattai Vallathagi 
      Colour            Dark  Brown 
      Odour              Pleasant  
      Taste        Characteristic taste 
      Texture            Semi solid 
 
5.2 PHYSICOCHEMICAL ANALYSIS
*
 
Table :2 Physicochemical properties of Pattai Vallathagi 
 
 
 
 
 
 
 
 
 
             
 
 
**The Experimental Procedure  was analyzed at Captain Srinivasa murti Reseach 
Institute  of Ayurveda and Siddha Drug Development, Arumbakkam, Chennai-106. 
S.NO Parameters Results 
1.  pH at 10% of aqueous solution 6.50 
2. Total   Ash 2.40% 
3. Acid insoluble ash 0.19% 
4. Loss on drying@105˚C 3.25% 
5. Specific gravity 1.10 
6. Fat content   39.47 
7. Reducing Sugar 3.00 
8. Total  Sugar 15.51 
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5.3 Chemical Analysis of  Pattai Vallathagi
* 
Table 3 : Results of Acid radicals studies 
S.NO Parameter Observation Result 
1 Test for Sulphate Cloudy appearance was formed Positive 
2 Test for Chloride - Negative 
3 Test For Phosphate - Negative 
4 Test For Carbonate - Negative 
5 Test For Nitrate - Negative 
6 Test for Sulphide - Negative 
7 Test For Fluoride &oxalate - Negative 
8 Test For Nitrite - Negative 
9 Test For Borax - Negative 
 
Interpretation 
The acidic radicals test shows the presence of chemical sulphate. 
Table 4 :Results of basic radicals studies
* 
S.NO Parameter Observation Result 
1 Test for Lead - Negative 
2 Test for Copper - Negative 
3 Test For Aluminium - Negative 
4 Test For Iron. Mild red colour appeared Positive 
5 Test For Zinc - Negative 
6 Test for Calcium Cloudy appearance and white 
precipitate was formed 
Positive 
7 Test For Magnesium - Negative 
8 Test For Ammonium - Negative 
9 Test For Potassium Yellow precipitate was appeared Positive 
10 Test For Sodium - Negative 
11 Test For Mercury - Negative 
12 Test For Arsenic -  Negative 
Interpretation :The basic radical test shows the presence of Iron, cacium, , Potassium and 
absence of heavy metals such as lead, arsenic and mercury. 
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Table :5    Result for  other  constituents
* 
S. No Parameter Observation Result 
1. Test for starch - - 
2. Test for reducing sugar - - 
3. Test for Alkaloids No red colour developed Positive 
4. Test for Amino acid - - 
5. Test for Tannic acid Blue–black precipitate was 
obtained 
positive 
6. Test for type of compounds - - 
 
Table  shows the presence of alkaloids and tannic acid in Pattai Valathagi 
 
 
 
 
 
 
 
 
 
 
________________________________________________________________ 
*The  chemical analysis of    was carried out in Bio-chemistry Lab, National 
Institute Of Siddha  . 
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5.4 TLC  and HPTLC analysis 
The procedure recommended for the analysis of TLC  and  HPTLC analysis as per Wagner H 
and Bladt S, 1996 
Table:6 
        UV-254nm          UV-366nm         V-S Reagent 
        0.25  Green        0.88  Blue           0.12 Violet 
        0.31  Green        0.14  Blue            0.24 Violet 
        0.46  Green        0.18  Blue            0.31 Pink 
        0.65  Green        0.26  Yellow            0.51 Blue block 
         0.69 Green        0.31 Yellow            0.63 Brown 
        0.86  Green        0.61 Blue block            0.67 Blue block 
        0.95  Green        0.69 Blue            0.74 Pink 
        0.74 Blue            0.85 Violet 
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TLC PHOTODOCUMENTATION OF DTL SAMPLE CODES 1510352 
                                     
 
 
                                                       
 
Solvent system : Toluene : Ethyl acetate (9:1) 
Track 1: 5 µ1 Sample, Track 2: 10 µ1 Sample  
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  _________________________________________________________________________       
*The Experimental Procedure  was analyzed at Captain Srinivasa Murthi Research 
Institute  of Ayurveda and Siddha Drug Development, Arumbakkam, Chennai-106. 
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5.5  Heavy Metals Analysis of   Pattai vallathagi
* 
Table 7 :  
 
S. No. Name of the Element Results Permissible Limit 
1 Lead 4.62ppm 10 ppm (WHO) 
2 Cadmium 0.31ppm 0.3 ppm (WHO) 
3 Mercury 0.012ppm 1 ppm (API) 
 
From Table (7)  the heavy metals in Pattai Vallathagi were found to be with in normal limits 
except Cadmium which is nearer to the permissible limit. 
5.6  Microbial analysis of   Pattai Vallathagi 
* 
Table 8: Screening for Micro – organisms:   
S.No Parameters Results 
Permissible Limit for 
Internal use 
1 Total  Bacterial Count (TBC)  0.5x 10
3 
CFU/g         10
5 
CFU/g 
2 Total  Fungal  Count (TBC)     <10
3
         10
3 
CFU/g 
3 Enterobacteriaceae     Absent         10
3 
CFU/g 
4 Escherichia coli     Absent         10
 
CFU/g 
5 Salmonella spp     Absent            Absent 
6 Staphylococcus aureus     Absent            Absent 
 
 
 
 
 
___________________________________________________________________________            
*The Experimental Procedure  was analyzed at Captain Srinivasa murthi Research 
Institute  of Ayurveda and Siddha Drug Development, Arumbakkam, Chennai-106. 
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5.7 ELEMENTAL ANALYSIS 
         The analytical results of heavy metals and  trace elements in Pattai Vallathagi using 
ICP-OES are showed in table  
Table 9. ICP- OES study results of Pattai vallathagi 
 
 
BDL-Below Detection Limit, ppm –Parts per million 
Table (9) : shows the quantitative analysis of the elements present in Pattai Vallathagi, The 
heavy metals were found to be with in normal limits. 
 
 
                                      
 
 
________________________________________________________________ 
 *The Experimental Procedure was done at SAIF, IIT Madras, Chennai-36. 
S.No Elements Wavelength in  nm mg/L 
1 Arsenic As188.979 BDL 
2 Calcium Ca 315.807 32.860 mg/L 
3 Cadmium Cd 228.802 BDL 
4 Copper Cu 327.393 BDL 
5 Lead Pb 220.353 BDL 
6 Mercury Hg 253.652 BDL 
7 Nickel Ni 231.604 BDL 
8 Potassium K 766.491 04.621 mg/L 
9 Phosphorus P 213.617 16.941 mg/L 
10 Sodium Na 589.592 04.810mg/L 
11 Sulphur S180.731 81.374mg/L 
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SCANNED ELECTRON  MICROSCOPY 
5.8.Determination of particle size of  Pattai Vallathagi 
Figure 1   
 
 
         The picture shows that the particles are stabilize, have irregular morphology and 
distributed in near micron. Pattai Vallathagi has particle size of  1.2-2.4 µ 
 
 
 
 
 
 
________________________________________________________________
***The Experimental Procedure was done at SAIF, IIT Madras, Chennai-36. 
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ACUTE ORAL TOXICITY STUDY OF  PATTAI VALLATHAGI
* 
Table 10    :  Dose finding experiment and its behavioural Signs of Toxicity 
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 5 + - - - - + - - - - - - - - - - - - - - 
2 50 + - - - - + - - - - - - - - - - - - - - 
3 300 + - - - - + - - - - - - - - - - - - - - 
4 2000 + - - - - + - - - - - - - - - - - - - - 
 
1.Alertness 2.Aggressiveness 3.Pile erection 4.Grooming 5.Gripping 6.Touch Response 
7.Decreased Motor activity 8.Tremors 9.Convulsions 10.Muscle Spasm 11.catatonia 
12.Muscle relaxant 13.Hypnosis 14.Analgesia 15.Lacrimation 16.Exophthalmos 17.Diarrhoea 
18. Writhing 19.Respiration 20.Mortality 
+   Presence Of Activity 
_  Absence Of Activity                                            
Result : 
           All data were summarized in the form of table ( 10 )revealed no abnormal signs and 
behavioral changes in rats at the dose of 5, 50, 300 & 2000 mg/kg body weight administered 
orally. 
 
 
 
 
 
______________________________________________________________ 
*The Acute oral toxicity study was done at K.K College of  Pharmacy, 
Gerugambakkam 
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28 DAYS REPEATED ORAL TOXICITY STUDY OF 
                                     PATTAI  VALLATHAGI 
Table 11  :Body weight (g) of  wistar albino rats  group exposed to Pattai Vallathagi  for 
28 days 
DOSE 0 7 14 21 28 
CONTROL 163.42+5.00 165.52+6.00 166.24+5.25 168.05+5.21 171.10+5.26 
MID DOSE 165.17+1.15 166.41+5.11 170.12+5.72 172.61+6.00 174.51+5.28 
HIGH DOSE 166.20+5.47 168.10+6.00 171.18+6.12 173.12+5.10 174.30+6.14 
 
Values are mean of a 10 animals ± S.E.M (Dunnet‟s test) *p<0.05 ;**p<0.01.N=10 
Table 12: Water intake (ml/day) of wistar albino rats group exposed to Pattai 
Vallathagi for 28 days 
DOSE 
DAYS 
0 7 14 21 28 
CONTROL 30.31±0.36 30.45±0.32 30.68±0.25 30.80±0.20 30.6±0.20 
MID DOSE 31.02±0.48 31.19±0.32 31.16±0.16 31.36±0.08 31.01±0.16 
HIGH DOSE 31.46±0.08 31.32±0.16 31.61±0.39 31.12±0.40 31±0.02 
 
Values are mean of a 10 animals ± S.E.M (Dunnet‟s test) *p<0.05 ;**p<0.01.N=10 
Table 13: Food intake (gms/day) of wistar albino rats group exposed to Pattai 
Vallathagi for 28 days 
DOSE 
DAYS 
0 7 14 21 28 
CONTROL 20.66±0.81 22.16±0.25 24.23±0.36 23.73±0.43 24.33±0.81 
MID DOSE 21.12±0.23 22.71±0.16 24.81.±0.39 24.13±0.63 25.12±0.51 
HIGH DOSE 21.67±0.15 22.62±0.13 25±0.15 24.65±0.57 25.92±0.44 
Values are mean of a 10 animals ± S.E.M (Dunnet‟s test)* p<0.05 ;**p<0.01.N=10 
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Table  14. Haematological parameters (28 days – sub acute) 
          PARAMETERS CONTROL MID DOSE HIGH DOSE 
Total RBC  count (×10
6
 mm−3) 9.09±0.25 9.10±0.04 9.09±0.07 
Total WBC Count (×10
3
 mm−3). 11.41±0.21 11.52±0.11 11.66±0.43 
Haemoglobin (Hb) (g/dl) 15.26±0.21 14.7±0.52 15.1±0.43 
Platelets (×103 mm−3). 410.0±9.70 423.16±4.83 430.1±4.64 
PCV % 39.11±0.34 39.25±0.41 39.86±0.18 
MCV (ft) 51.02±0.21 51.43±0.29 51.8±0.21 
Values are mean of a 10 animals ± S.E.M (Dunnet‟s test) *p<0.05 ;**p<0.01.N=10 
Chart 1  : The mean value of  Hb, T.RBC Count of  control and treated groups of  
wistar albino rats exposed to Pattai Vallathagi for 28 days 
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Chart 2  :The mean value of  Platelets of control and treated groups of wistar albino 
rats  exposed to Pattai Vallathagi for 28 days 
 
Chart 3  : The mean value  of T.WBC Count,PCV, MCV of  control and treated groups of 
wistar albino rats exposed to Pattai Vallathagi  for 28 days 
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Table 15:Effect of treatment with Pattai Vallathagi on biochemical parameters: 
                                     Liver function  test 
PARAMETERS CONTROL MID DOSE HIGH DOSE 
Total Bilirubin(mg/dl) 0.7±0.08 0.65±0.17 0.7±0.14 
Bilirubin direct(mg/dl) 0.3±0.06 0.35±0.10 0.35±0.05 
Bilirubin indirect(mg/dl) 0.4±0.06 0.31±0.10 0.35±0.10 
ALP(U/L) 110.83±2.23 114.83±0.75 115.66+1.03 
AST(U/L) 55.33±2.25 56.33±1.21 56.52±1.87 
ALT(U/L) 68.38±0.57 68.21±0.95 68.66±1.03 
Totalprotein(g/dl) 5.10±0.14 5.34±0.03 5.25±0.03 
Albumin(g/dl) 3.19±0.02 3.20±0.01 3.23±0.02 
Globulin(g/dl) 6.36±0.03 6.41±0.01 6.43±0.04 
    Values are mean of a 10 animals ± S.E.M (Dunnet‟s test) *p<0.05 ;**p<0.01.N=10 
Chart  4 : The mean value of T.Bilirubin, Direct & Indirect Bilirubin of control and 
treated groups of wistar albino rats exposed to Pattai Vallathagi  for 28 days
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Chart 5  : The mean value of  ALP,AST,ALT of control and treated groups of wistar 
albino rats exposed to Pattai Vallathagi  for 28 days 
 
 
 
Chart   6:  The mean value of Total protein , Albumin, Globulin of control and treated 
groups of wistar albino rats exposed to Pattai Vallathagi  for 28 days 
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Table 16: Effect of treatment with Pattai Vallathagi on renal parameters: 
                                       Renal function test  
PARAMETERS CONTROL MID DOSE HIGH DOSE 
Urea(mg/dl) 15.23±0.47 15.11±0.11 15.99±0.11 
Creatinine(mg/dl) 0.55±0.05 0.62±0.03 0.66±0.01 
Uric acid(mg/dl) 2.35±0.22 2.22±0.20 2.27±0.14 
Na m.mol 145.50±0.55 146.50±0.55 146.66±0.52 
K m.mol 4.51±0.01 4.72±0.02 4.87±0.20 
Cl m.mol 98.20±0.10 100.20±0.10 100.30±1.10 
Values are mean of a 10animals ± S.E.M (Dunnet‟s test) *p<0.05 ;**p<0.01.N=10 
Chart 7   : The mean value of Urea of control and treated groups of wistar albino rats 
exposed to Pattai Vallathagi  for 28 days 
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Chart 8  :The mean value of Creatinine, Uric acid of  control and treated groups of 
wistar albino  rats exposed to Pattai Vallathagi  for 28 days 
 
Chart   9  :  The mean value of Na,K,Cl of control and treated groups of wistar albino 
rats exposed to Pattai Vallathagi  for 28 days 
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Table 17: Effect of treatment with Pattai Vallathagi on Lipid Profile 
 
 
Values are mean of a 10 animals ± S.E.M (Dunnet‟s test) *p<0.05 ;**p<0.01.N=10 
Chart 10 : The mean value of T.Cho, HDL,LDL,VLDL.Triglycerides of  control and 
treated groups of wistar albino rats exposed to  Pattai Vallathagi  for 28 days 
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PARAMETERS CONTROL MID DOSE HIGH DOSE 
Total cholesterol (mg/dl) 63.6±8.5 64.50±5.2 62.5±.8.7 
HDL(mg/dl) 12.05±0.02 12.11±0.05 12.22±0.09 
LDL(mg/dl) 35.83±0.42 36.73±0.36 37.18±0.70 
VLDL (mg/dl) 15.80±0.03 15.81±0.02 15.72±0.04 
Triglycerides(mg/dl) 78.33±0.52 76.0±1.26 76.35 ±0.82 
TC/HDL ratio (g/dl) 3.18±0.04 3.11±0.04 3.22±0.03 
Blood glucose (mg/dl) 121.90±0.66 121.84±0.82 121.98±0.36 
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Chart   11  : The mean value of  Blood Glucose of control and treated groups of wistar 
albino rats exposed to Pattai Vallathagi  for 28 days 
 
Table 18: Urine Analysis 
PARAMETERS CONTROL MID DOSE HIGH DOSE 
Transparency Clear Slightly turbid Slightly turbid 
Specific gravity 1.010 1.010 1.010 
PH >7.0 >7.2 >7.2 
Protein Nil Nil Nil 
Glucose Nil Nil Nil 
Bilirubin -ve -ve -ve 
Ketones -ve -ve -ve 
Blood  Absent Absent Absent 
Urobilinogen Normal Normal Normal 
Pus cells 0-cells/HPF 0-cells/HPF 1-cells/HPF 
RBC Nil Nil 1-cells/HPF 
Epithelial cells Nil 1-cells/HPF Nil 
Crystals Nil Nil Nil 
Casts Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen 
Colour Yellow Yellow Yellow 
 
Values are mean of a 10 animals ± S.E.M (Dunnet‟s test)* p<0.05 ;**p<0.01.N=10 
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Table 19: Effect of Pattai Vallathagi   on organ weight after 28 days treatment in rats 
 
PARAMETER CONTROL MID DOSE HIGH DOSE 
Liver 4.51+0.44 4.03+0.39 4.50+041 
Heart 1.05+0.10 1.18+1.13 1.1+0.11 
Lung 0.83+020 0.93+0.09 0.90+0.08 
Spleen 0.64+0.07 0.58+0.07 0.57+0.06 
Ovary 1.69+0.14 1.78+0.15 1.78+0.18 
Testes 1.48+0.10 1.66+0.15 1.69+0.15 
Brain 1.56+0.15 1.56+0.14 1.56+0.14 
Kidney 1.05+0.10 1.18+0.13 1.1+0.11 
Stomach 1.36+0.12 1.38+0.11 1.38+0.11 
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( Fig 2)HISTOPATHOLOGICAL STUDIES OF VARIOUS ORGANS AFTER THE 28 
DAYS REPEATED DOSE ORAL TOXICITY STUDY OF  PATTAI VALLATHAGI        
IN WISTAR ALBINO RATS 
                                                        HEART         
           a. Control                                                                    b. Mid Dose         
                                                                                          
                        
                                               c.   
 
 
High Dose 
                                       
 
  
 
Observations 
a) Section of the heart  showed normal muscle fibres with acidophilic cytoplasm and 
centrally located nuclei. 
 
b) Section of the heart  showed normal muscle fibres with acidophilic cytoplasm and 
centrally located nuclei  
 
c)  Section of the heart  showed normal muscle fibres with acidophilic cytoplasm and 
centrally located nuclei 
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LIVER 
     a. Control                                                                          b.Mid Dose  
                                         
                                                                                                                                                                                        
c. High dose 
                                                                              
 
 
 
 
Observations 
a) Section of liver  from control animals  showed no degeneration of hepatocytes, focal 
steatosis, congestion of central vein and inflammation of portal tract . 
b) Section of liver showed no degeneration of hepatocytes, focal steatosis, congestion of 
central vein and inflammation of portal tract  
c)  Section of liver showed no degeneration of hepatocytes, focal steatosis, congestion of 
central vein and inflammation of portal tract 
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KIDNEY 
a.Control                                                           b. Mid dose  
                              
 
                                                         
 
 
c. High dose 
                                           
                                                
   
 
Observations 
a) Section of kidney from control animals  showed normal  size of glomeruli with 
normal tubules. 
 
b) Section of kidney showed normal glomeruli and there is no necrosis of tubular 
epithelium in the kidney. 
 
c) Section of kidney showed normal glomeruli and there is no necrosis of tubular 
epithelium in the kidney 
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SPLEEN 
                       a. Contral                    b.Mid dose 
 
 
    
 
                                  
 
c.High dose 
                                            
 
 
 
 
Observations 
a) Section of spleen from control animal showed normal granular hemosiderin pigment 
predominantly within macrophages in the red pulp. 
 
b) Section of spleen showed normal granular hemosiderin pigment predominantly within 
macrophages in the red pulp with normal structure. 
 
c) Section of spleen showed normal granular hemosiderin pigment predominantly within 
macrophages in the red pulp with normal structure 
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BRAIN 
                    a. Control                                                b. Mid dose 
                                            
                                                                 
 
 
 
 
c. High dose 
                                                         
 
 
 
 
 
Observation  
a. Section of  brain from control animals  showed  brain cortex with normal architecture. 
b. Section of brain Treated animals showed brain cortex with normal architecture. 
c.  Section of brain Treated animals showed brain cortex with normal architecture 
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REPEATED DOSE 28 DAYS  ORAL TOXICITY STUDY 
Results : 
Sub-acute oral toxicity repeated dose of Pattai vallathagi on rats were conducted. All 
animals from the treated dose survived throughout the dosing period of 28 days. Various 
parameters were studied and the interpretation of the study result is  discussed below. 
Clinical signs: 
No abnormal behavioural signs were observed during the study period. 
Mortality 
 The test drug “Pattai Vallathagi” did not cause any mortality in mid and high dose 
levels and were considered as safe dose levels.  
Body weight: 
The result of the body weight of rats exposed to control and the trial drug of different 
dose groups exhibited overall mild weight gain through out the dosing period of 28 days. The 
quantity of food taken by the animals from different dose groups and the control is 
comparably normal. 
 Haematological investigation interpretation 
The haematological investigation results of the rats conducted on 28th day after the 
repeated dose of the drug revealed the values of different parameters. The increase and 
decrease in the values obtained were  all within the normal biological and laboratory limits. 
Biochemical investigation interpretation 
The biochemical investigations were conducted on 28th day and the result is 
produced. The results revealed there is no significant changes in the values of different 
parameters with that of the control. All the values were within the normal biological and 
laboratory limits. 
Histopathology interpretation : 
   The histopathological study of the organs such as heart, liver, spleen,kidney and 
Brain were normal in control, and all test groups. 
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90 DAYS REPEATED DOSE ORAL TOXICITY STUDY : 
Table  20 :  Body weight of wistar albino rats group exposed to    
                                                Pattai vallathagi For 90 days 
 
NS- Not Significant, **(p < 0.01),*(p <0.05), n =6  values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test 
Table 21:  Haematological parameters of Wistar albino rats group exposed to Pattai 
Vallathagi for 90 days (sub chronic toxicity study ) 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
 
DAYS 
Weight(gms)/Days 
 
P value (p)
* 
Control Low dose Mid dose High dose 
1 162.4±29.65 162.29 ± 21.83 163± 13.09 162.5± 28.17 NS 
15 161 ± 28.49 162.8 ± 23.54 171.7 ± 29.83 179.8 ± 32.13 NS 
30 184.4 ± 28.83 184.71 ± 14.76 182.8 ± 32.17 190.2 ± 28.55 NS 
45 202.7± 27.81 205.6± 29.12 203.1± 19.07 207.9± 22.05 NS 
60 226.6±33.47 232.6±23.91 230.6±33.61 226.6±23.63 NS 
75 240.8 ± 26.76 244.8 ± 28.08 242.0± 28.70 240.8 ±26.87 NS 
90 263.5± 27.94 266.9± 27.68 268.2± 27.31 266.1± 29.41
 
NS 
Parameter Control Low dose Mid dose High dose 
P value 
(p)* 
Haemoglobin(g/dl) 12.88±0.54 12.83±0.38 13.48±0.98 12.96±0.50 N.S 
Total WBC 
(cells/cu.mm) 
11.2±4.6 10.9±6.6 11.5±4.6 11.3±3.3 N.S 
Platelets cells/ul 353.2±0.32 339.1±0.23 366.1±0.23 377.3±0.08 N.S 
Total RBC 
(cells/cu.mm) 
7.33±0.21 7.08±0.19 7.33±0.33 7.11±0.45 N.S 
PCV% 38.62±1.60 38.49±1.17 40.48±2.94 38.81±1.60 N.S 
MCV (ft) 89.16±2.71 91.66±3.55 89.33±3.72 92.66±2.87 N.S 
MCH(pg) 33.5  ±  3.01 30.5  ±  3.83 32.16  ±  3.48 30.66 ±  1.03 N.S 
MCHC (gm/dl) 33.33±2.50 36.5±1.87 35±2.36 36±4.77 N.S 
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Chart 12: The mean value of HB, Total RBC, Total WBC of control and treated 
groups of wistar albino rats exposed to Pattai Vallathagi for 90 days 
 
 
 
Chart 13:  The mean value of Platelets  of control and treated groups of wistar albino 
rats exposed to Pattai Vallathagi  for 90days 
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Chart 14 :  The mean value of PCV,MCV,MCH,MCHC of control and treated groups 
of wistar albino rats exposed to Pattai Vallathagi for 90 days 
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Table 22 :  Blood sugar test of Wistar albino rats group exposed to      Pattai Vallathagi 
for 90 days 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
Bl.sugar 
(mg/dl) 
124.66±7.31 123.66±11.62 113.92±2.87 119.12±4.41 N.S. 
 
N.S- Not Significant, **(p < 0.01), *(p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
Chart 15: The mean value of Blood sugar of control and treated groups of wistar albino 
rats exposed to Pattai vallathagi for 90 days 
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Table 23:  Renal function test of Wistar albino rats group  exposed to Pattai Vallathagi 
for 90days 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
UREA (mg/dl) 29±6.32 27.66±7.71 23.83±6.08 28.83±7.19 N.S 
CREATININE(mg/dl) 0.58±0.19 0.73±0.12 0.45±0.10 0.58±0.20 N.S 
NS- Not Significant, **(p < 0.01), * (p <0.05) , n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
Chart 16:  The mean value of Urea of control and treated groups of wistar albino rats 
exposed to Pattai Vallathagi  for 90 days 
                        
 
  Chart 17:  The mean value of Creatinine of control and treated groups of wistar albino 
rats exposed to Pattai Vallathagi  for 90 days 
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Table 24: Sub chronic toxicity - Lipid profile test of Wistar albino rats group  exposed 
to Pattai Vallathagi  for 90 days 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE P Value (p)* 
Tcho(mg/dl) 119.16±5.34 119.6±6.53 116.56±10.41 120.33±4.88 N.S 
HDL(mg/dl) 41.83±3.65 46±3.16 47.64±5.08 39.16±4.21 N.S 
LDL(mg/dl) 49.33±6.43 48.83±6.79 39.29±10.16 52.66±5 N.S 
VLDL(mg/dl) 27.93±2.27 25.06±1.04 27.13±4.05 28.4±1.62 N.S 
\TGL(mg/dl) 139.66±11.37 125.33±5.24 135.66±20.27 142±8.12 N.S 
 
N.S- Not Significant, **(p <0.01), *(p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
Chart 18:  The mean value of  Lipid profile of control and treated groups of wistar 
albino rats exposed to Pattai vallathagi  for 90 days 
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 Table 25:  Liver Function Test of Wistar albino rats group  exposed to Pattai 
Vallathagi for 90 days 
 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
P Value 
(p)* 
T.BILIRUBIN(mg/dl) 0.68±0.17 0.63±0.15 0.76±0.103 0.68±0.07 N.S 
SGOT(U/L) 24.16±6.90 22.5±4.84 28.33±3.01 23.5  ±   6.59 N.S 
SGPT(U/L) 25.33±9.85 28.83±5.19 26.5±3.27 22.66±3.98 N.S 
ALP(U/L) 63±8.07 77.33±17.03 69.16±16.24 63.33±6.08 N.S 
 
NS- Not Significant, **(p <0.01), * (p <0.05), n = 6 values are mean ± S.D (One way 
ANOVA followed by Dunnett‟s test) 
Chart 19 :  The mean value of  T.Bilirubin of control and treated groups of wistar 
albino rats exposed to Pattai vallathagi  for 90 days 
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Chart 20: The mean value of SGOT, SGPT,ALP  of control and treated groups of 
wistar albino rats exposed to Pattai Vallathagi  for 90 days 
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( Fig 3)HISTOPATHOLOGICAL STUDIES OF VARIOUS ORGANS AFTER THE 90 
DAYS REPEATED DOSE ORAL TOXICITY STUDY OF  PATTAI VALLATHAGI        
IN WISTAR ALBINO RATS 
                Control - Heart                                               High dose -  Hear                                                
                                                    
  
 
 
                    Control – Liver                                                         High dose - Liver                                                 
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    Control –Spleen                                                       High dose  - Spleen   
                                  
 
 
 
 
 
 
 
 
  Control – Brain                                                             High dose - Brain 
                                  
 
 
 
 
 
Observation : 
Heart 
 Atrial and ventricular wall of both the heart sample appears normal 
 Appearance of cardiomyocyte was normal with dark nuclear region. The nuclei of 
muscle fibers appear central arrangement. 
Liver 
 Appearance of portal vein, bile duct and hepatic artery was normal 
 Hepatocellular architecture, including hepatic sinusoid and hepatic cord was normal. 
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Kidney 
 Glomerular cell integrity, basement membrane and nephrotic bundle appears normal 
 No signs of lesion or inflammation were observed 
 Proximal and distal convoluted tubule appears normal 
Spleen  
 Appearance of LF – lymphoid follicle; PALS – periarterial lymphoid sheath was 
normal with no significant signs of enlargement 
 Presence of marginal at the interface of the red pulp with the PALS and follicles was 
observed 
Brain 
 Arrangement of the neurons appears intact with no sings of degeneration or apoptotic 
changes in both the samples 
 Cortex region showed normal neurons with polygonal to round cell bodies containing 
dense cytoplasm. 
RESULTS OF REPEATED DOSE 90 DAYS ORAL TOXICITY STUDY : 
Repeated dose 90 days oral toxicity study of Pattai Vallathagi on rats were 
conducted. All animals from the treated dose survived throughout the dosing period of 90 
days. No abnormal behavioural signs were observed during the study period. 
 The result of the body weight of rats exposed to control and the trial drug of different 
dose groups exhibited over all mild weight gain throughout the dosing period of 90 days.  
The haematological and bio chemical investigations were conducted on 91th day after 
the repeated dose of the drug revealed there is no significant changes in the values of 
different parameters with that of the control.  
Histopathological study of the organ such as heart, kidney, liver, spleen and Brain 
were normal in control and  test groups. 
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Table  26 : Pharmacological analysis  :Effect of pattai Vallathagi on cotton pellet 
induced granuloma model 
Groups Treatment 
Mean wet 
weight of 
pellet(mg) 
Percentage 
inhibition 
Mean dry 
weight of 
pellet(mg) 
Percentage 
inhibition 
I  Control 195.50±2.17 0 45.60±1.39 0 
II Dexamethasone(0.5mg/kg) 92.33±3.46** 52.77 20.88±0.72** 54.21 
III Pattai  vallathagi(200mg/kg) 170.33±3.61* 12.88 35.63±1.02* 19.86 
IV Pattai  vallathagi(400mg/kg) 135.16±4.07** 30.86 30.68±0.28** 26.56 
 
N= 6, values are expressed as mean± SEM ,P<0.01 when compared with control. The results 
were analyzed by ANOVA followed by Dunnet‟s test (P value less than 0.01 was considered 
as statistically significant 
Chart 21 :Effect of pattai Vallathagi on the mean wet of cotton pellet induced 
granuloma model 
 
0
50
100
150
200
103 
 
Chart 22 :Effect of pattai Vallathagi on percentage inhibition on wet   cotton pellet 
induced granuloma model 
 
 
Chart 23 :Effect of pattai Vallathagi on mean dry of cotton pellet induced granuloma 
model 
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Chart 24 : Effect of pattai Vallathagi on percentage inhibition on dry cotton pellet 
induced granuloma model 
 
 
 
RESULTS  
The results indicate that Pattai vallathagi at the dose level of 200mg/kg and 
400mg/kg produced a decrease in wet granuloma weight 170.33±3.61* (12.88% inhibition) 
and 135.16±4.07**(30.86% inhibition) respectively when compared with control . Similarly 
there was a significant decrease in dry granuloma weight 35.63±1.02*(19.86% inhibition) 
and 30.68±0.28**(26.56% inhibition) respectively when compared with control.  Among the 
two doses 400 mg/kg showed slightly lower reduced weight of granuloma than standard drug  
which was showed in table 26. Thus it was concluded that administration of Pattai Vallathagi 
at the dose of 400 mg/kg exhibited significant (p<0.01) anti -inflammatory activity in Cotton 
pellet granuloma model of inflammation in rats. 
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Table 27  : Pharmacological analysis – Analgesic activity of Pattai Vallathagi in Swiss 
albino mice  
Groups Treatment 
 
                                 Reaction time in sec 
0min 30min 60min 90min 120min 150min 
I Control 2.02±0.16 2.04±0.10 2.12±0.10 2.16±0.16 2.12±0.12 2.14±0.12 
II 
Pentazoci
ne 
(5mg/kg) 
2.29±0.17 5.09±0.12* 6.32±0.06** 7.02±0.10** 8.22±0.14** 
12.12±0.01
** 
 
III 
Low dose 
(200mg/k
g) 
2.18±0.02 2.60±0.04 3.22±0.08 4.10±0.12* 5.86±0.12* 6.10±0.08* 
IV 
High dose 
400mg/kg
). 
2.24±0.21 3.02±0.01 4.20±0.04* 6.02±0.15** 7.08±0.18** 8.10±0.02* 
N= 6, values are expressed as mean± SEM ,P<0.05,P<0.01 when compared with control. The 
results were analyzed by ANOVA followed by Dunnet‟s test (P value less than 0.05,0.01 was 
considered as statistically significant 
Chart  25 :Analgesic activity of Pattai Vallathagi in Eddy’s Hot plate method 
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Result of Analgesic activity of  Pattai Vallathagi in swiss albino mice 
Analgesic activity was carried out by Eddy‟s Hot plate method. Pattai Vallathagi at 
the two doses 200 mg/kg showed significant (p<0.05) analgesic activity at reaction time 90 
min (4.10±0.12*) and 400 mg/kg showed significant (p<0.01) analgesic activity at  120 min 
(7.08±0.18**) was slightly lower than the standard drug Pentazocine 8.22±0.14**. 
From these results it was obvious that Pattai Vallathagi has significant analgesic 
activity. 
Table28  : Pharmacological analysis -Antihistaminic activity of pattaiVallathagi using                                     
guinea pig ileum preparation   
S.No 
Dose of 
histamine 
Log molar 
concentration 
of Histamine 
Control 
%maximum 
response 
Standard% 
Maximum 
response 
pattai 
Vallathagi 
% 
Maximum 
response 
1 0.1ml 7.08 15.20±1.01 10.01±1.46** 12.02±0.21** 
2 0.2ml 6.79 20.82±1.06 12.21±2.01** 15.20±1.22** 
3 0.4ml 6.48 27.62±1.22 14.45±1.04** 20.21±1.46** 
4 0.8ml 6.18 32.42±1.26 20.12±2.31** 26.01±2.02** 
5 1.6ml 5.88 40.02±1.22 22.04±1.04** 30.42±1.01** 
 
Values are expressed as mean±SEM (n=6).**P<0.01 when compared to control group. 
Chart  26  : Anti-histamine activity of Pattai Vallathagi in ileum cut terminal method 
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Graph : Pharmacological analysis – Anti- histamine activity of Pattai Vallathagi in 
albino guinea pig 
 
Result of anti- histamine activity : 
        Histamine was released from mast cells and basophiles by antigenic stimulation causing 
smooth muscle contraction, increased vascular permeability and mucus formation. Mast cells 
with their mediator can be regarded as centre for initiation and mediation of early phase of 
allergic reaction and may be responsible for initiation of chronic allergic reaction.The 
stimulation of H1 receptors produces graded dose related contraction of isolated guinea pig 
ileum.In the present study the trial drug Pattai Vallathagi significantly inhibited the 
histamine induced contraction of isolated guinea pig ileum preparation,indicating Anti- 
histamine activity 
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9.DISCUSSION 
 
The drug  Pattai vallathagi  was selected from the Siddha literature 
  “Siddha anuboga vaithiya   navaneetha  thirattu (part -10)”   to validate the safety and  its 
pharmacological activities (  anti-inflammatory, analgesic and anti- histamine) in animal 
model.   
 The ingredients of the test drug was identified and authenticated by Siddha experts. 
The drug was prepared as per the procedure and subjected to various studies such as 
qualitative, quantitative, toxicity and pharmacological activities. Qualitative analysis includes 
Chemical analysis and Physico- chemical properties of Pattai Vallathagi. 
 Quantitative analysis included ICP-OES and HR SEM analysis to reveal its potency 
and effectiveness against the disease. 
From the above analysis we came to know the presence of active ingredients 
responsible for its activity. 
 
Literary collections: 
 Literary collections include drug review, which consist of both Botanical aspect, 
Gunapadam aspect, Pharmacological review that supported the study. 
 
Chemical analysis: 
          Chemical analysis of the drug Pattai Vallathagi revealed the presence of  Sulphate, 
Calcium, Iron,Photassium,  tannic acid and alkaloid. 
 
Calcium : 
        Skin disease may occur as a symptom of calcium deficiency.Presence of calcium in 
Pattai Vallathagi is useful in skin disease. 
Pottasium : 
       Skin disease associated with nervousness may occur as a result of potassium 
deficiency.The  existence of potassium in Pattai Vallathagi,So it is useful in skin disease. 
Tannic acid
(27) 
 The properties of tannic acid are anti-bacterial,anti-dermatoic anti septic 
properties.Thus it work well in skin disease 
             These chemical elements present in Pattai Vallathagi  enhances the anti histamine 
activity of the drug. 
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              The microbial load analysis confirms  Pattai Vallathagi was free from microbial 
organisms and fungal infections. 
In ICP-OES study, heavy metals were found below detection limit in Pattai 
Vallathagi. Calcium, Potassium, Phosporous, sodium, sulphur  were present. 
In HR SEM analysis, the particle size of Pattai Vallathagi  was analyzed and 
reported. This ensures the absorption of the drug was more active and the drug have increased 
bio-availability. 
 
Toxicological studies: 
          In acute oral toxicity study, there were no abnormal signs and behavioral changes in 
rats upto the dose level of 2000 mg/kg body weight administered orally. No mortality was 
observed in all groups. No abnormalities was seen in external observation and necropsy 
examination on the dose level of 5, 50,300 mg/kg b.w and 2000 mg/kg b.w. All the vital 
organs were normal. 
In 28 days Repeated oral toxicity and 90 days Repeated oral toxicity study , the 
experimental animals were sacrificed by excessive anesthesia and blood samples were 
collected and sent for investigation. There were no significant changes in body weight, food 
and water intake, hematological parameters, renal parameters, Liver function test , Lipid 
profile and blood glucose level. The organs were collected and sent for histopathology study. 
It revealed the organs such as heart, kidney, liver, splean, brain was normal in Control, Mid 
dose and High dose. Thus the toxicological study of the test drug greatly establishes the 
safety and gives the justification for long time administration. 
 
Pharmacological studies: 
 
The pharmacological study was carried out in the animal model Wistar albino rats 
swiss albino  mice and guinea pig. Three activities were seen in the drug Pattai Vallathagi  
The activities were 
             Anti- inflammatory  
 Analgesic  
Anti -histamine 
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Anti- inflammatory activity 
Administration of Pattai Vallathagi at the dose of 200 mg/kg and 400 mg/kg 
exhibited significant anti - inflammatory activity in Cotton pellet granuloma mothod. 
Analgesic activity 
Administration  of Pattai Vallathagi at the dose of 200 mg/kg and 400 mg/kg 
exhibited significant analgesic activity in Eddy‟s Hot plate method. 
Anti – histamine  
             In the present study the trial drug Pattai Vallathagi significantly inhibited the 
histamine induced contraction of isolated guinea pig ileum preparation,indicating Anti- 
histamine activity 
            From the discussion,  it is concluded that the test drug  Pattai Vallathagi  is a safe and 
a potent anti- histamine drug. It also possess rich Analgesic and Anti inflammatory activity. 
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111 
 
                                                   10.SUMMARY 
 
 The test drug Pattai Vallathagi  was selected from the siddha literature 
          “Siddha anuboga vaithiya   navaneetha  thirattu (part -10)” for its anti-inflammatory, 
             analgesic  and  anti-histamine activities. 
 
 The test drug was prepared  by the given procedure. All the ingredients  were 
identified and authenticated by the experts. 
 
 Review of literature in various categories was carried out. Siddha aspect, botanical 
aspect disclosed about the drug and the disease. 
 
 The drug was subjected to analysis such as physicochemical, 
phytochemical,biochemical and also instrumental analysis which provided the key 
ingredients  present in the drug thus it accounts the efficacy of the drug 
 
 Toxicological study was made according to OECD guidelines comprising  acute, sub-
acute  and sub chronic toxicity study. It screens  the safety of the drug which 
attributes its utility in long time administration. 
 
 Pharmacological study was done. It revealed the anti-inflammatory,analgesic and  
anti-histamine activities. and activities of Pattai Vallathagi  in animal model Wistar 
albino rat,mice and guinea pig 
 
 Results and discussion gives the proper justifications to prove the potency of  the 
drug. 
 
 Thus the herbao mineral  formulation Pattai Vallathagi  is validated for its 
           safety and efficacy for treating skin diseases and it would be a great drug of choice. 
 
 
  
 
 
Conclusion 
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                                                           11.CONCLUSION 
 
From the literature evidence, Physico chemical analysis,  chemical analysis, 
Toxicological evaluation and Pharmacological studies, the author concludes that the  drug 
Pattai vallathagi  is safe and it has significant effect in  anti-inflammatory, analgisic and 
anti - histamine activities It is concluded that the drug Pattai vallathagi can be used in the 
management of skin diseases which is cost effective and easy to prepare. 
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